Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2023 | Aug. 10, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-40913 | |
Entity Registrant Name | Alpine 4 Holdings, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 46-5482689 | |
Entity Address, Address Line One | 2525 E Arizona Biltmore Circle | |
Entity Address, Address Line Two | Suite 237 | |
Entity Address, City or Town | Phoenix | |
Entity Address, State or Province | AZ | |
Entity Address, Postal Zip Code | 85016 | |
City Area Code | 480 | |
Local Phone Number | 702-2431 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | false | |
Entity Ex Transition Period | true | |
Registrant CIK | 0001606698 | |
Fiscal Year End | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Class A Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 24,224,657 | |
Class B Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 906,012 | |
Class C Common Stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 1,528,533 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 | |
CURRENT ASSETS: | |||
Cash | $ 3,828,963 | $ 2,673,541 | |
Accounts receivable, net | 16,628,748 | 17,139,944 | |
Inventory | 24,019,013 | 25,258,369 | |
Contract assets | 1,392,007 | 1,402,788 | |
Prepaid expenses and other current assets | 2,134,045 | 2,428,223 | |
Total current assets | 48,002,776 | 48,902,865 | |
Property and equipment, net | 19,861,909 | 19,503,485 | |
Intangible assets, net | 34,668,042 | 36,282,609 | |
Right of use assets, net | 15,704,511 | 16,407,566 | |
Goodwill | 22,680,084 | 22,680,084 | |
Other non-current assets | 1,693,603 | 1,855,605 | |
TOTAL ASSETS | 142,610,925 | 145,632,214 | |
CURRENT LIABILITIES: | |||
Accounts payable | 15,807,557 | 8,608,554 | |
Accrued expenses | 6,570,507 | 6,749,890 | |
Contract liabilities | 5,854,696 | 5,284,285 | |
Lines of credit | 8,699,609 | 7,426,814 | |
Convertible note payable, current portion | 471,311 | 0 | |
Financing lease obligation, current portion | 764,267 | 725,302 | |
Operating lease obligation, current portion | 1,518,842 | 1,318,885 | |
Total current liabilities | 46,412,261 | 33,314,866 | |
Notes payable, net of current portion | 2,144,048 | 4,266,350 | |
Lines of credit, net of current portion | 4,058,411 | 7,215,520 | |
Financing lease obligations, net of current portion | 14,195,602 | 14,592,813 | |
Operating lease obligations, net of current portion | 14,447,193 | 15,262,494 | |
Deferred tax liability | 333,708 | 988,150 | |
TOTAL LIABILITIES | 81,591,223 | 75,640,193 | |
Commitments & Contingencies (Note 8) | |||
STOCKHOLDERS' EQUITY | |||
Additional paid-in capital | [1] | 143,072,462 | 141,723,921 |
Accumulated deficit | [1] | (82,055,404) | (71,734,395) |
Total stockholders' equity | [2] | 61,019,702 | 69,992,021 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 142,610,925 | 145,632,214 | |
Nonrelated Party | |||
CURRENT LIABILITIES: | |||
Notes payable, current portion | 6,170,472 | 3,201,136 | |
Related Party | |||
CURRENT LIABILITIES: | |||
Notes payable, current portion | 555,000 | 0 | |
Series B Preferred Stock | |||
STOCKHOLDERS' EQUITY | |||
Preferred stock | [1] | 3 | 5 |
Class A Common Stock | |||
STOCKHOLDERS' EQUITY | |||
Common stock | [1] | 2,397 | 2,230 |
Class B Common Stock | |||
STOCKHOLDERS' EQUITY | |||
Common stock | [1] | 91 | 107 |
Class C Common Stock | |||
STOCKHOLDERS' EQUITY | |||
Common stock | [1] | $ 153 | $ 153 |
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details.[2]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) | Jun. 30, 2023 $ / shares shares | Dec. 31, 2022 $ / shares shares |
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Series B Preferred Stock | ||
Preferred stock, par value (in dollars per share) | $ / shares | $ 1 | $ 1 |
Preferred stock, shares authorized (in shares) | 100 | 100 |
Preferred stock, shares issued (in shares) | 3 | 5 |
Preferred stock, shares outstanding (in shares) | 3 | 5 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 200,000,000 | 200,000,000 |
Common stock, shares issued (in shares) | 23,974,657 | 22,303,333 |
Common stock, shares outstanding (in shares) | 23,974,657 | 22,303,333 |
Class B Common Stock | ||
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Common stock, shares issued (in shares) | 906,012 | 1,068,512 |
Common stock, shares outstanding (in shares) | 906,012 | 1,068,512 |
Class C Common Stock | ||
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 |
Common stock, shares issued (in shares) | 1,528,533 | 1,529,888 |
Common stock, shares outstanding (in shares) | 1,528,533 | 1,529,888 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | |||||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | ||||
Income Statement [Abstract] | |||||||
Revenues, net | $ 28,022,026 | $ 25,271,126 | $ 52,383,739 | $ 50,863,280 | |||
Cost of revenues | 20,234,936 | 19,110,583 | 39,380,193 | 39,065,280 | |||
Gross profit | 7,787,090 | 6,160,543 | 13,003,546 | 11,798,000 | |||
Operating expenses: | |||||||
General and administrative expenses | 9,893,454 | 9,216,398 | 20,136,477 | 18,418,080 | |||
Research and development | 1,612,530 | 394,835 | 1,726,436 | 586,765 | |||
Gain on sale of property | 0 | (5,822,450) | 0 | (5,822,450) | |||
Total operating expenses | 11,505,984 | 3,788,783 | 21,862,913 | 13,182,395 | |||
Income (loss) from operations | (3,718,894) | 2,371,760 | (8,859,367) | (1,384,395) | |||
Other income (expenses) | |||||||
Interest expense | (1,108,745) | (962,474) | (2,107,615) | (1,571,435) | |||
Other income | 15,906 | 258,660 | 59,106 | 291,379 | |||
Total other expenses | (1,092,839) | (703,814) | (2,048,509) | (1,280,056) | |||
Income (loss) before income tax | (4,811,733) | 1,667,946 | (10,907,876) | (2,664,451) | |||
Income tax (benefit) | (259,867) | 128,140 | (586,867) | (204,697) | |||
Net income (loss) | $ (4,551,866) | [1] | $ 1,539,806 | [1] | $ (10,321,009) | $ (2,459,754) | |
Weighted average shares outstanding | |||||||
Basic (in shares) | [2] | 25,103,271 | 22,899,822 | 25,076,452 | 22,890,560 | ||
Diluted (in shares) | [2] | 25,103,271 | 22,899,822 | 25,076,452 | 22,890,560 | ||
Basic income (loss) per share (in dollars per share) | $ (0.18) | $ 0.07 | $ (0.41) | $ (0.11) | |||
Diluted income (loss) per share (in dollars per share) | $ (0.18) | $ 0.07 | $ (0.41) | $ (0.11) | |||
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details.[2]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
CONSOLIDATED STATEMENTS OF OP_2
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) | May 12, 2023 |
Class A Common Stock | |
Conversion ratio | 0.125 |
CONSOLIDATED STATEMENTS CHANGES
CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDER'S EQUITY - USD ($) | Total | Conversion of Class B Common Stock to Class A Common Stock | Conversion of Series B Preferred Stock to Class A Common Stock | Conversion of Series D preferred stock to Class A | Conversion of Series C preferred stock to Class A | Additional Paid-in Capital | Additional Paid-in Capital Conversion of Series B Preferred Stock to Class A Common Stock | Additional Paid-in Capital Conversion of Series D preferred stock to Class A | Additional Paid-in Capital Conversion of Series C preferred stock to Class A | Accumulated Deficit | Series B Preferred Stock | Series B Preferred Stock Preferred Stock | Series B Preferred Stock Preferred Stock Conversion of Series B Preferred Stock to Class A Common Stock | Class A Common Stock | Class A Common Stock Common Stock | Class A Common Stock Common Stock Conversion of Class B Common Stock to Class A Common Stock | Class A Common Stock Common Stock Conversion of Series B Preferred Stock to Class A Common Stock | Class A Common Stock Common Stock Conversion of Series D preferred stock to Class A | Class A Common Stock Common Stock Conversion of Series C preferred stock to Class A | Class B Common Stock | Class B Common Stock Common Stock | Class B Common Stock Common Stock Conversion of Class B Common Stock to Class A Common Stock | Class C Common Stock | Class C Common Stock Common Stock | |||||
Beginning balance (in shares) at Dec. 31, 2021 | [1] | 5 | |||||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | [1] | 20,224,938 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Beginning balance at Dec. 31, 2021 | [1] | $ 71,491,476 | $ 130,348,267 | $ (58,859,082) | $ 5 | $ 2,022 | $ 107 | $ 156 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Conversion of convertible securities (in shares) | [1] | 7,989 | 1,031 | ||||||||||||||||||||||||||
Conversion of convertible securities | [1] | $ 365,464 | $ 34,622 | $ 365,463 | $ 34,622 | $ 1 | |||||||||||||||||||||||
Issuance of shares of common stock for compensation (in shares) | [1] | 4,924 | |||||||||||||||||||||||||||
Issuance of shares of common stock for compensation | [1] | 99,248 | 99,248 | ||||||||||||||||||||||||||
Share-based compensation expense | [1] | 93,197 | 93,197 | ||||||||||||||||||||||||||
Net loss | [1] | (3,999,560) | (3,999,560) | ||||||||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2022 | [1] | 5 | |||||||||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2022 | [1] | 20,238,882 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Ending balance at Mar. 31, 2022 | [1] | 68,084,447 | 130,940,797 | (62,858,642) | $ 5 | $ 2,023 | $ 107 | $ 156 | |||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | [1] | 5 | |||||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | [1] | 20,224,938 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Beginning balance at Dec. 31, 2021 | [1] | 71,491,476 | 130,348,267 | (58,859,082) | $ 5 | $ 2,022 | $ 107 | $ 156 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Net loss | (2,459,754) | ||||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | [1] | 5 | |||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | [1] | 20,269,879 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Ending balance at Jun. 30, 2022 | [1] | 69,983,882 | 131,300,423 | (61,318,836) | $ 5 | $ 2,026 | $ 107 | $ 156 | |||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2022 | [1] | 5 | |||||||||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2022 | [1] | 20,238,882 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Beginning balance at Mar. 31, 2022 | [1] | 68,084,447 | 130,940,797 | (62,858,642) | $ 5 | $ 2,023 | $ 107 | $ 156 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Issuance of shares of common stock for compensation (in shares) | [1] | 21,482 | |||||||||||||||||||||||||||
Issuance of shares of common stock for compensation | [1] | 132,309 | 132,307 | $ 2 | |||||||||||||||||||||||||
Shares issued from ATM (in shares) | [1] | 9,515 | |||||||||||||||||||||||||||
Shares issued from ATM | [1] | 55,137 | 55,136 | $ 1 | |||||||||||||||||||||||||
Share-based compensation expense | [1] | 172,183 | 172,183 | ||||||||||||||||||||||||||
Net loss | [1] | 1,539,806 | 1,539,806 | ||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | [1] | 5 | |||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | [1] | 20,269,879 | 1,068,512 | 1,562,635 | |||||||||||||||||||||||||
Ending balance at Jun. 30, 2022 | [1] | 69,983,882 | 131,300,423 | (61,318,836) | $ 5 | $ 2,026 | $ 107 | $ 156 | |||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 5 | 5 | [1] | ||||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 22,303,333 | 22,303,333 | [1] | 1,068,512 | 1,068,512 | [1] | 1,529,888 | 1,529,888 | [1] | ||||||||||||||||||||
Beginning balance at Dec. 31, 2022 | [1] | 69,992,021 | 141,723,921 | (71,734,395) | $ 5 | $ 2,230 | $ 107 | $ 153 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Conversion of convertible securities (in shares) | [1] | 1,428 | (1,428) | ||||||||||||||||||||||||||
Series B Preferred Share removal (in shares) | [1] | (1) | |||||||||||||||||||||||||||
Series B Preferred Share removal | [1] | 0 | 1 | $ (1) | |||||||||||||||||||||||||
Share-based compensation expense | [1] | 182,589 | 182,589 | ||||||||||||||||||||||||||
Net loss | [1] | (5,769,143) | (5,769,143) | ||||||||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2023 | [1] | 4 | |||||||||||||||||||||||||||
Ending balance (in shares) at Mar. 31, 2023 | [1] | 22,304,761 | 1,068,512 | 1,528,460 | |||||||||||||||||||||||||
Ending balance at Mar. 31, 2023 | [1] | 64,405,467 | 141,906,511 | (77,503,538) | $ 4 | $ 2,230 | $ 107 | $ 153 | |||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 5 | 5 | [1] | ||||||||||||||||||||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 22,303,333 | 22,303,333 | [1] | 1,068,512 | 1,068,512 | [1] | 1,529,888 | 1,529,888 | [1] | ||||||||||||||||||||
Beginning balance at Dec. 31, 2022 | [1] | 69,992,021 | 141,723,921 | (71,734,395) | $ 5 | $ 2,230 | $ 107 | $ 153 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Net loss | (10,321,009) | ||||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2023 | 3 | 3 | [1] | ||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2023 | 23,974,657 | 23,974,657 | [1] | 906,012 | 906,012 | [1] | 1,528,533 | 1,528,533 | [1] | ||||||||||||||||||||
Ending balance at Jun. 30, 2023 | [1] | 61,019,702 | 143,072,462 | (82,055,404) | $ 3 | $ 2,397 | $ 91 | $ 153 | |||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2023 | [1] | 4 | |||||||||||||||||||||||||||
Beginning balance (in shares) at Mar. 31, 2023 | [1] | 22,304,761 | 1,068,512 | 1,528,460 | |||||||||||||||||||||||||
Beginning balance at Mar. 31, 2023 | [1] | 64,405,467 | 141,906,511 | (77,503,538) | $ 4 | $ 2,230 | $ 107 | $ 153 | |||||||||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||||||||||||||||
Conversion of convertible securities (in shares) | [1] | (1) | 1,477,400 | 162,500 | 1 | (162,500) | |||||||||||||||||||||||
Conversion of convertible securities | [1] | 1,000,809 | $ 0 | $ 0 | 1,000,661 | $ 1 | $ (1) | $ 148 | $ 16 | $ (16) | |||||||||||||||||||
Adjustment for additional shares issued in connection with the reverse stock split (in shares) | [1] | 29,995 | 73 | ||||||||||||||||||||||||||
Adjustment for additional shares issued in connection with the reverse stock split | [1] | 3 | $ 3 | ||||||||||||||||||||||||||
Share-based compensation expense | [1] | 165,289 | 165,289 | ||||||||||||||||||||||||||
Net loss | [1] | (4,551,866) | (4,551,866) | ||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2023 | 3 | 3 | [1] | ||||||||||||||||||||||||||
Ending balance (in shares) at Jun. 30, 2023 | 23,974,657 | 23,974,657 | [1] | 906,012 | 906,012 | [1] | 1,528,533 | 1,528,533 | [1] | ||||||||||||||||||||
Ending balance at Jun. 30, 2023 | [1] | $ 61,019,702 | $ 143,072,462 | $ (82,055,404) | $ 3 | $ 2,397 | $ 91 | $ 153 | |||||||||||||||||||||
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
CONSOLIDATED STATEMENTS CHANG_2
CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDER'S EQUITY (Parenthetical) | May 12, 2023 |
Class A Common Stock | |
Conversion ratio | 0.125 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
OPERATING ACTIVITIES: | ||
Net loss | $ (10,321,009) | $ (2,459,754) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation | 1,498,572 | 1,564,357 |
Amortization | 1,614,567 | 1,454,099 |
Gain on sale of property | 0 | (5,822,450) |
Stock compensation expense | 348,029 | 496,957 |
Income tax benefit | (654,442) | (204,697) |
Amortization of debt discounts | 96,729 | 0 |
Non-cash lease expense | 703,055 | 224,422 |
Write off of inventory | 276,898 | 71,552 |
Bad debt expense | 330,544 | 115,835 |
Changes in current assets and liabilities: | ||
Accounts receivable | 180,652 | (1,257,649) |
Inventory | 962,458 | 672,426 |
Contract assets | 10,781 | (608,743) |
Prepaid expenses and other assets | 456,180 | (765,887) |
Accounts payable | 7,199,003 | 1,084,278 |
Accrued expenses | (179,383) | 1,257,019 |
Contract liabilities | 570,411 | (2,846,166) |
Operating lease liability | (615,344) | (213,041) |
Net cash provided by (used) in operating activities | 2,477,701 | (7,237,442) |
INVESTING ACTIVITIES: | ||
Capital expenditures | (1,856,996) | (756,870) |
Proceeds from sale of building | 0 | 12,454,943 |
Net cash provided by (used) in investing activities | (1,856,996) | 11,698,073 |
FINANCING ACTIVITIES: | ||
Proceeds from the sale of common stock, net of offering costs | 0 | 55,144 |
Net proceeds/(repayments) from lines of credit | (1,947,538) | 3,436,740 |
Proceeds from issuance of convertible notes, non-related party | 2,090,000 | 0 |
Debt issuance costs | (651,533) | 0 |
Repayment of building mortgage | 0 | (4,642,043) |
Repayments of notes payable, non-related parties | (182,111) | (2,540,390) |
Cash paid on financing lease obligations | (358,246) | (317,150) |
Net cash provided by (used) in financing activities | 534,717 | (4,007,699) |
NET INCREASE IN CASH | 1,155,422 | 452,932 |
CASH, BEGINNING BALANCE | 2,673,541 | 3,715,666 |
CASH, ENDING BALANCE | 3,828,963 | 4,168,598 |
CASH PAID FOR: | ||
Interest | 2,107,615 | 1,224,984 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES: | ||
ROU asset and operating lease obligation recognized | 0 | 8,725,000 |
Equipment purchased on note payable | 0 | 243,843 |
Series B Preferred Share Removal | 2 | 0 |
Conversion of Series D preferred stock for common stock | 0 | 400,092 |
Nonrelated Party | ||
FINANCING ACTIVITIES: | ||
Proceeds from issuances of notes payable | 1,029,145 | 0 |
Related Party | ||
FINANCING ACTIVITIES: | ||
Proceeds from issuances of notes payable | $ 555,000 | $ 0 |
Organization and Basis of Prese
Organization and Basis of Presentation | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Basis of Presentation | Organization and Basis of Presentation The unaudited consolidated financial statements were prepared by Alpine 4 Holdings, Inc. ("we,” “our,” or the "Company"), pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") were omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 5, 2023. The results for the six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2023. The Company was incorporated under the laws of the State of Delaware in April 2014. We are a publicly traded conglomerate that acquires businesses that fit into our disruptive DSF business model of Drivers, Stabilizers, and Facilitators. Basis of presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Certain reclassifications have been made that have no impact on net earnings and financial position. Liquidity The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board (“FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued (further detail in the Going Concern sub-section below). As shown in the accompanying consolidated financial statements, the Company has incurred significant recurring losses but has positive cash flows from operations for the current year. Although the Company has experienced net losses of $10.3 million and $2.5 million for the six months ended June 30, 2023 and 2022, respectively, net cash flows provided by operating activities improved to $2.5 million for the six months ended June 30, 2023, from $7.2 million used in operating activities for the six months ended June 30, 2022. As of June 30, 2023, the Company had positive working capital of $1.6 million, which was a decrease of $14.0 million compared to December 31, 2022. The Company has bank financing totaling $35.0 million ($35.0 million in lines of credit including $0.5 million in capital expenditures lines of credit availability) of which $4.4 million was available and unused as of June 30, 2023. There are three lines of credit that are set to mature during the next twelve months. These three lines of credit total $13.7 million, of which $8.7 million was used as of June 30, 2023, and are shown as a current liability on the consolidated balance sheet. These factors raise substantial doubt about the Company's ability to continue as a going concern. The Company plans to continue to generate additional revenue, improve cash flows from operations, and improve gross profit performance across all of its subsidiaries. The Company also may raise funds through debt financing, securing additional lines of credit, and the sale of shares in public or private offerings. Going Concern The accompanying financial statements have been prepared on a going concern basis. While the working capital deficiency of prior years has improved, and working capital of the Company is currently positive, continued operating losses cause doubt as to the ability of the Company to continue. The Company's ability to raise additional capital through the future issuances of common stock is unknown. The obtainment of additional financing, the successful development of the Company's plan of operations, and its ultimate transition to profitable operations are necessary for the Company to continue. The uncertainty that exists with these factors raises substantial doubt about the Company's ability to continue as a going concern. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties. In order to mitigate the risk related to the going concern uncertainty, the Company has a three-fold plan to resolve these risks. First, the operating subsidiaries of Quality Circuit Assembly ("QCA"), Quality Circuit Assembly - Central ("QCA-C"), Identified Technologies ("IDT"), Thermal Dynamics International ("TDI"), and RCA Commercial ("RCA") plan to expand their revenues and profits yielding increased cash flow in those operating segments. This plan will allow for an increased level of cash flow to the Company. Second, the Company has expanded its credit facilities at the subsidiary level over the past twelve months to allow for greater borrowing accessibility if needed for the expansion of product lines and sales opportunities and plans to extend or refinance any lines of credit coming due over the next twelve months in order to provide additional financing. Finally, operating companies hard hit by the supply-chain related price increases such as Morris Sheet Metal ("MSM"), Alternative Laboratories ("Alt Labs"), and Excel Construction ("Excel") have begun to experience an easing in the procurement and cost overruns of limited product supply. This subsequently has added to increased cash flow to those entities and less reliance on the Company to fund those activities. Although this plan is in place to mitigate the risk related to the going concern uncertainty, substantial doubt remains due to uncertainty around the growth projections and lack of control of many of the factors included in the Company’s plan. Entity level risks Our operations and performance may depend on global, regional, economic and geopolitical conditions. Russia’s invasion and military attacks on Ukraine have triggered significant sanctions from North American and European leaders. As of the date of this Report, those events were continuing to escalate and create increasingly volatile global economic conditions. Resulting changes in North American trade policy could trigger retaliatory actions by Russia, its allies and other affected countries, including China, resulting in a “trade war.” A trade war could result in increased costs for raw materials that we use in our manufacturing and could otherwise limit our ability to sell our products abroad. These increased costs would have a negative effect on our financial condition and profitability. Furthermore, the military conflict between Russia and Ukraine is increasing supply interruptions and further hindering our ability to find the materials we need to make our products. If the conflict between Russia and Ukraine continues for a long period of time, or if other countries become further involved in the conflict, we could face significant adverse effects to our business and financial condition. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2023 and beyond. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2 – Summary of Significant Accounting Policies Principles of consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of June 30, 2023, and December 31, 2022. Significant intercompany balances and transactions have been eliminated. Use of estimates The consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. This applies in particular to useful lives of long-lived assets, reserves for accounts receivable and inventory, valuation allowance for deferred tax assets, fair values assigned to intangible assets acquired, and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. Cash Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of June 30, 2023, and December 31, 2022, the Company had no cash equivalents. The FDIC insures up to $250,000 per account with any excess amount in each account being uninsured. Total bank balances were $3.9 million and $3.2 million as of June 30, 2023, and December 31, 2022, respectively. Of this amount, $2.5 million and $2.0 million were uninsured as of June 30, 2023, and December 31, 2022, respectively. All uninsured amounts are held with J.P. Morgan Chase. Major Customers & Vendors The Company had no customers which made up over 10% of total Company accounts receivable as of June 30, 2023, or December 31, 2022. For the six months ended June 30, 2023, the Company had no customers which made up over 10% of total Company revenues. For the six months ended June 30, 2022, the Company had one customer within the A4 Technology - RCA segment, which made up 12% of total Company revenues. For the six months ended June 30, 2023 and 2022, the Company received 10% and 10%, respectively, of total Company revenues from prime contractors. For the six months ended June 30, 2023, the Company had no vendors, which made up over 10% of total Company purchases. For the six months ended June 30, 2022, the Company had one vendor within the A4 Technology - RCA segment, which made up 17% of total Company purchases. Inventory Inventory for all subsidiaries is valued at weighted average cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower. Inventory is segregated into three areas, raw materials, work-in-process and finished goods. Inventory at June 30, 2023, and December 31, 2022, consisted of: June 30, 2023 December 31, 2022 Raw materials $ 9,726,538 $ 9,116,824 Work in process 3,528,187 3,165,876 Finished goods 10,764,288 12,975,669 Inventory $ 24,019,013 $ 25,258,369 Impairment of Long-Lived Assets The Company accounts for long-lived assets in accordance with the provisions of ASC Topic 360, Accounting for the Impairment of Long-Lived Assets. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when the estimated future cash flows from the use of the asset is less than the carrying amount of that asset. During the six months ended June 30, 2023, there were no events or changes in circumstances that indicated a quantitative impairment analysis was necessary and as such, no impairment was recorded. Goodwill In financial reporting, goodwill is not amortized, but is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Events that result in an impairment review include significant changes in the business climate, declines in our operating results, or an expectation that the carrying amount may not be recoverable. We assess potential impairment by considering present economic conditions as well as future expectations. All assessments of goodwill impairment are conducted at the individual reporting unit level. As of June 30, 2023, and December 31, 2022, the reporting units with goodwill were QCA, MSM, Alt Labs, TDI, IDT, Elecjet, and RCA. Consistent with our prior year assessment, the Elecjet reporting unit is considered an at-risk reporting unit. Our methods and assumptions were consistent with those discussed below in the Fair Value Measurement subsection. This reporting unit is primarily considered at-risk as it is a start-up subsidiary with minimal to no revenue to offset its research & development expenses. The DCF model includes revenue growth assumptions of us executing large new customer and/or supplier agreements within the next two years and then steadily increasing revenue at a more normalized rate thereafter. Any failure to execute these customer and/or supplier arrangements would negatively impact the key growth assumptions. Fair value measurements Accounting Standards Codification ("ASC") 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. We apply the provisions of fair value measurement to various nonrecurring measurements for our financial and nonfinancial assets and liabilities. The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. We calculate the estimated fair value of a reporting unit using a combination of the income and market approaches. For the income approach, we use a discounted cash flow models developed in connection with our third-party valuation specialists that include the following assumptions, among others: projections of revenues, expenses, and related cash flows based on assumed long-term growth rates; and estimated discount rates. For the market approach, we use analyses based primarily on market comparables. We base these assumptions on historical data and experience, industry projections, and general economic conditions. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of June 30, 2023, and December 31, 2022, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis, as all of our financial assets and liabilities were Level 1. Equity Method Investments In February 2023, the Company made a $0.3 million investment for a 10% equity interest in a battery materials company, which includes a seat on its board of directors, and participation rights in future funding rounds. The investment is accounted for as an equity method investment as the board representation allows us to have significant influence over the operating and financial policies of the battery materials company. The investment is presented in other non-current assets on the consolidated balance sheet with the value of the investment being adjusted in arrears on a quarterly basis based on its financial performance. In June 2023, a subsequent funding round was held, in which the Company waived its participation rights, that decreased our equity investment to an 8% equity interest. Research and Development The Company focuses on quality control and development of new products and the improvement of existing products. All costs related to research and development activities are expensed as incurred. During the six months ended June 30, 2023 and 2022, research and development costs totaled $1.7 million and $0.6 million, respectively. Earnings (loss) per share The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The amount of anti-dilutive shares related to stock options and warrants as of June 30, 2023 and 2022 was 2,894,897 and 1,098,050. respectively. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) inclusive of all classes of common stock as the only difference between the classes of common stock are related to the voting rights for the three and six months ended June 30, 2023 and 2022: For the Three Months Ended June 30, 2023 For the Three Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Income Shares Per Share Amount Basic EPS Net income (loss) $ (4,551,866) 25,103,271 $ (0.18) $ 1,539,806 22,899,822 $ 0.07 Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (4,551,866) $ 25,103,271 $ (0.18) $ 1,539,806 $ 22,899,822 $ 0.07 For the Six Months Ended June 30, 2023 For the Six Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS Net loss $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) Revenue Recognition The Company recognizes revenue under ASC Topic 606, Revenue from contract with Customers ("Topic 606"). The following is a summary of the revenue recognition policy for each of the Company’s subsidiaries. Revenue is recognized under Topic 606, at a point in time and over a period of time, in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements: – executed contract with the Company's customers that it believes are legally enforceable; – identification of performance obligations in the respective contract; – determination of the transaction price for each performance obligation in the respective contract; – allocation of the transaction price to each performance obligation; and – recognition of revenue only when the Company satisfies each performance obligation. The following tables presents our revenues disaggregated by type for the three months ended June 30, 2023 and 2022: Three Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 12,886,116 $ — $ 8,660,465 $ — $ 21,546,581 Sale of services 3,660,886 — 2,413,363 — 401,196 6,475,445 Total revenues $ 3,660,886 $ 12,886,116 $ 2,413,363 $ 8,660,465 $ 401,196 $ 28,022,026 Three Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 7,530,475 $ — $ 9,255,658 $ — $ 16,786,133 Sale of services 5,669,259 — 2,472,207 — 343,527 8,484,993 Total revenues $ 5,669,259 $ 7,530,475 $ 2,472,207 $ 9,255,658 $ 343,527 $ 25,271,126 The following tables presents our revenues disaggregated by type for the six months ended June 30, 2023 and 2022: Six Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 22,206,937 $ — $ 16,216,383 $ — $ 38,423,320 Sale of services 7,806,890 — 5,383,450 — 770,079 13,960,419 Total revenues $ 7,806,890 $ 22,206,937 $ 5,383,450 $ 16,216,383 $ 770,079 $ 52,383,739 Six Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 16,178,570 $ — $ 19,049,646 $ — $ 35,228,216 Sale of services 9,725,463 — 5,160,188 — 749,413 15,635,064 Total revenues $ 9,725,463 $ 16,178,570 $ 5,160,188 $ 19,049,646 $ 749,413 $ 50,863,280 |
Leases
Leases | 6 Months Ended |
Jun. 30, 2023 | |
Leases [Abstract] | |
Leases | Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate. As of June 30, 2023, the future minimum finance and operating lease payments were as follows: Twelve Months Ending June 30, Finance Operating 2024 $ 1,938,360 $ 2,412,039 2025 1,944,246 2,304,494 2026 1,848,756 1,784,228 2027 1,890,900 1,823,449 2028 1,932,830 1,646,961 Thereafter 13,879,717 12,457,744 Total payments 23,434,809 22,428,915 Less: imputed interest (8,474,940) (6,462,880) Total obligation 14,959,869 15,966,035 Less: current portion (764,267) (1,518,842) Non-current financing leases obligations $ 14,195,602 $ 14,447,193 Finance Leases As of June 30, 2023, all finance leases in the table above were related to property and equipment. Depreciation expense associated with the finance leases within property and equipment, net was $625,908 and $625,908 for the six months ended June 30, 2023 and 2022, respectively. Of this amount $89,006 and $0 is recorded within cost of revenues with the remainder recorded in general & administrative expenses on the consolidated statements of operations for the six months ended June 30, 2023 and 2022, respectively. Interest expense on finance leases for the six months ended June 30, 2023, and 2022 was $607,895 and $633,610, respectively, and is recorded in interest expense on the consolidated statements of operations. At June 30, 2023, the weighted average remaining lease terms were 11.5 years, and the weighted average discount rate was 8.01%. Operating Leases The table below presents the operating lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of June 30, 2023, and December 31, 2022: June 30, December 31, Assets Operating lease assets Operating lease right of use assets $ 15,704,511 $ 16,407,566 Total lease assets $ 15,704,511 $ 16,407,566 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 1,518,842 $ 1,318,885 Noncurrent liabilities Operating lease liability Long-term operating lease liability 14,447,193 15,262,494 Total lease liability $ 15,966,035 $ 16,581,379 The lease expense for the six months ended June 30, 2023 and 2022, were $1,292,535 and $253,121, respectively. Of this amount $372,352 and $0 were recorded within cost of revenues with the remainder recorded in general and administrative expense on the consolidated statements of operations for the six months ended June 30, 2023 and 2022, respectively. The cash paid under operating leases during the six months ended June 30, 2023 and 2022, were $789,282 and $251,398, respectively. At June 30, 2023, the weighted average remaining lease terms were 11.5 years, and the weighted average discount rate was 6.01%. |
Leases | Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate. As of June 30, 2023, the future minimum finance and operating lease payments were as follows: Twelve Months Ending June 30, Finance Operating 2024 $ 1,938,360 $ 2,412,039 2025 1,944,246 2,304,494 2026 1,848,756 1,784,228 2027 1,890,900 1,823,449 2028 1,932,830 1,646,961 Thereafter 13,879,717 12,457,744 Total payments 23,434,809 22,428,915 Less: imputed interest (8,474,940) (6,462,880) Total obligation 14,959,869 15,966,035 Less: current portion (764,267) (1,518,842) Non-current financing leases obligations $ 14,195,602 $ 14,447,193 Finance Leases As of June 30, 2023, all finance leases in the table above were related to property and equipment. Depreciation expense associated with the finance leases within property and equipment, net was $625,908 and $625,908 for the six months ended June 30, 2023 and 2022, respectively. Of this amount $89,006 and $0 is recorded within cost of revenues with the remainder recorded in general & administrative expenses on the consolidated statements of operations for the six months ended June 30, 2023 and 2022, respectively. Interest expense on finance leases for the six months ended June 30, 2023, and 2022 was $607,895 and $633,610, respectively, and is recorded in interest expense on the consolidated statements of operations. At June 30, 2023, the weighted average remaining lease terms were 11.5 years, and the weighted average discount rate was 8.01%. Operating Leases The table below presents the operating lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of June 30, 2023, and December 31, 2022: June 30, December 31, Assets Operating lease assets Operating lease right of use assets $ 15,704,511 $ 16,407,566 Total lease assets $ 15,704,511 $ 16,407,566 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 1,518,842 $ 1,318,885 Noncurrent liabilities Operating lease liability Long-term operating lease liability 14,447,193 15,262,494 Total lease liability $ 15,966,035 $ 16,581,379 The lease expense for the six months ended June 30, 2023 and 2022, were $1,292,535 and $253,121, respectively. Of this amount $372,352 and $0 were recorded within cost of revenues with the remainder recorded in general and administrative expense on the consolidated statements of operations for the six months ended June 30, 2023 and 2022, respectively. The cash paid under operating leases during the six months ended June 30, 2023 and 2022, were $789,282 and $251,398, respectively. At June 30, 2023, the weighted average remaining lease terms were 11.5 years, and the weighted average discount rate was 6.01%. |
Debt
Debt | 6 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Debt and Convertible Debt | Debt The outstanding balances for the loans as of June 30, 2023, and December 31, 2022, were as follows: June 30, December 31, Lines of credit, current portion $ 8,699,609 $ 7,426,814 Equipment loans, current portion 76,072 68,410 Related party term notes, current portion 555,000 — Term notes, current portion 6,094,400 3,132,726 Total current 15,425,081 10,627,950 Lines of credit, net of current portion 4,058,411 7,215,520 Long-term portion of equipment loans and term notes 2,144,048 4,266,350 Total notes payable and lines of credit $ 21,627,540 $ 22,109,820 Future scheduled maturities of outstanding debt are as follows: Twelve Months Ending June 30, 2024 $ 15,425,081 2025 1,743,815 2026 669,034 2027 123,428 2028 3,594,396 Thereafter 71,786 Total $ 21,627,540 In August 2020, the Company filed a lawsuit against Alan Martin regarding his note payable. As of June 30, 2023 and 2022, the note had a balance of $2.9 million, and accrued interest and late fees of $2.0 million, which are reflective in current liabilities. The default rate was 10% and the daily late charge was $575. On July 31, 2023, the Company and Mr. Martin agreed to a settlement agreement to resolve litigation surrounding this matter (See a description of the Company’s ongoing legal proceedings relating to this transaction in Note 8, Commitments and Contingencies, below). During May 2023, the Company issued a $0.2 million nine-month note payable to an outside investor with an annual interest rate of 15%, with the proceeds to be used for general corporate purposes. In June 2023, Morris entered into a Forbearance agreement with its banking partner that extended the maturity of the line of credit to July 21, 2023 from May 31, 2023. In July 2023, Morris entered into an Amended Forbearance agreement extending the forbearance period until August 31, 2023. In June 2023, Quality Circuit Assembly entered into the third amendment on its loan and security agreement that increased the maximum limit to $7 million from $5 million. During 2023, the Company had four revolving lines of credit in the aggregate of $35.0 million, including one capital expenditures line of credit of $0.5 million. The revolving lines of credit used as of June 30, 2023, totaled $12.8 million with interest rates ranging from WSJ prime plus 2.50% - 4.25% and terms ranging from one In May 2023, the Company issued a one-year $0.4 million convertible note payable to an outside investor with an annual interest rate of 12% with the proceeds to be used for general corporate purposes. In connection with this convertible note payable, the Company issued 13,750 restricted shares of Class A Common Stock to the investor as additional consideration for the purchase of the note and 196,250 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. The convertible note was issued with an original issue discount of $24,500. The fair value of the shares issued was determined based on the closing stock price on the date of issuance and after allocating the proceeds was $243,529, which was recorded as debt issuance cost. The carrying value of the note as of June 30, 2023 was $185,476 and is recorded as convertible debt on the consolidated balance sheet. In June 2023, the Company issued a one-year $1.7 million convertible note payable to an outside investor with an annual interest rate of 12% with the proceeds to be used for general corporate purposes. In connection with this convertible note payable, the Company issued 67,400 restricted shares of Class A Common Stock to the investor as additional consideration for the purchase of the note and 1,200,000 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. The convertible note was issued with an original issue discount of $242,120. The fair value of the shares issued was determined based on the closing stock price on the date of issuance and after allocating the proceeds was $757,280, which was recorded as debt issuance cost. Further, the Company issued 200,000 warrants to purchase common stock to the investor and 3,579 warrants as a finders fee. The Company calculated the fair value of the warrants using a Black-Scholes option pricing model (Note 6) to be $378,000 and $6,764, respectively, which was recorded as a debt issuance cost. As the warrants have a change of control redemption feature, the warrants are classified as a liability within accrued expenses on the consolidated balance sheet. The carrying value of the note as of June 30, 2023 was $285,836 and is recorded as convertible debt on the consolidated balance sheet. All convertible debt is classified as a current liability on the balance sheet and matures within the next twelve months. |
Convertible Debt
Convertible Debt | 6 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Debt and Convertible Debt | Debt The outstanding balances for the loans as of June 30, 2023, and December 31, 2022, were as follows: June 30, December 31, Lines of credit, current portion $ 8,699,609 $ 7,426,814 Equipment loans, current portion 76,072 68,410 Related party term notes, current portion 555,000 — Term notes, current portion 6,094,400 3,132,726 Total current 15,425,081 10,627,950 Lines of credit, net of current portion 4,058,411 7,215,520 Long-term portion of equipment loans and term notes 2,144,048 4,266,350 Total notes payable and lines of credit $ 21,627,540 $ 22,109,820 Future scheduled maturities of outstanding debt are as follows: Twelve Months Ending June 30, 2024 $ 15,425,081 2025 1,743,815 2026 669,034 2027 123,428 2028 3,594,396 Thereafter 71,786 Total $ 21,627,540 In August 2020, the Company filed a lawsuit against Alan Martin regarding his note payable. As of June 30, 2023 and 2022, the note had a balance of $2.9 million, and accrued interest and late fees of $2.0 million, which are reflective in current liabilities. The default rate was 10% and the daily late charge was $575. On July 31, 2023, the Company and Mr. Martin agreed to a settlement agreement to resolve litigation surrounding this matter (See a description of the Company’s ongoing legal proceedings relating to this transaction in Note 8, Commitments and Contingencies, below). During May 2023, the Company issued a $0.2 million nine-month note payable to an outside investor with an annual interest rate of 15%, with the proceeds to be used for general corporate purposes. In June 2023, Morris entered into a Forbearance agreement with its banking partner that extended the maturity of the line of credit to July 21, 2023 from May 31, 2023. In July 2023, Morris entered into an Amended Forbearance agreement extending the forbearance period until August 31, 2023. In June 2023, Quality Circuit Assembly entered into the third amendment on its loan and security agreement that increased the maximum limit to $7 million from $5 million. During 2023, the Company had four revolving lines of credit in the aggregate of $35.0 million, including one capital expenditures line of credit of $0.5 million. The revolving lines of credit used as of June 30, 2023, totaled $12.8 million with interest rates ranging from WSJ prime plus 2.50% - 4.25% and terms ranging from one In May 2023, the Company issued a one-year $0.4 million convertible note payable to an outside investor with an annual interest rate of 12% with the proceeds to be used for general corporate purposes. In connection with this convertible note payable, the Company issued 13,750 restricted shares of Class A Common Stock to the investor as additional consideration for the purchase of the note and 196,250 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. The convertible note was issued with an original issue discount of $24,500. The fair value of the shares issued was determined based on the closing stock price on the date of issuance and after allocating the proceeds was $243,529, which was recorded as debt issuance cost. The carrying value of the note as of June 30, 2023 was $185,476 and is recorded as convertible debt on the consolidated balance sheet. In June 2023, the Company issued a one-year $1.7 million convertible note payable to an outside investor with an annual interest rate of 12% with the proceeds to be used for general corporate purposes. In connection with this convertible note payable, the Company issued 67,400 restricted shares of Class A Common Stock to the investor as additional consideration for the purchase of the note and 1,200,000 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. The convertible note was issued with an original issue discount of $242,120. The fair value of the shares issued was determined based on the closing stock price on the date of issuance and after allocating the proceeds was $757,280, which was recorded as debt issuance cost. Further, the Company issued 200,000 warrants to purchase common stock to the investor and 3,579 warrants as a finders fee. The Company calculated the fair value of the warrants using a Black-Scholes option pricing model (Note 6) to be $378,000 and $6,764, respectively, which was recorded as a debt issuance cost. As the warrants have a change of control redemption feature, the warrants are classified as a liability within accrued expenses on the consolidated balance sheet. The carrying value of the note as of June 30, 2023 was $285,836 and is recorded as convertible debt on the consolidated balance sheet. All convertible debt is classified as a current liability on the balance sheet and matures within the next twelve months. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2023 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders' EquityOn May 12, 2023, a Certificate of Amendment was filed to effect a one-for-eight (1-for-8) reverse split (the “Reverse Split”) of the shares of the Company’s the Class A, Class B, and Class C Common Stock, and to decrease the number of shares of Class A Common Stock from 295,000,000 shares to 200,000,000 shares (the “Class A Common Stock Decrease”). The Reverse Split and the Class A Common Stock Decrease became effective on May 12, 2023. As a result of the Reverse Split, every eight shares of the Company’s issued and outstanding Class A Common Stock automatically converted into one share of Class A Common Stock, without any change in the par value per share, and began trading on a post-split basis under the Company’s existing trading symbol, “ALPP,” when the market opened on May 15, 2023. Additionally, every eight shares of the Company’s issued and outstanding Class B Common Stock automatically converted into one share of Class B Common Stock, without any change in the par value per share, and every eight shares of the Company’s issued and outstanding Class C Common Stock automatically converted into one share of Class C Common Stock, without any change in the par value per share. The Reverse Split affected all holders of Class A, Class B, and Class C Common Stock uniformly and did not affect any common stockholder’s percentage ownership interest in the Company, except for de minimis changes as a result of the elimination of fractional shares. A total of 180,037,350 shares of Class A Common Stock were issued and outstanding immediately prior to the Reverse Split, and approximately 22,504,669 shares of common stock were issued and outstanding immediately after the Reverse Split. No fractional shares were outstanding following the Reverse Split. Any holder who would have received a fractional share of common stock automatically received an additional fraction of a share of common stock to round up to the next whole share. In addition, effective as of the same time as the Reverse Split, proportionate adjustments were made to all then-outstanding options and warrants with respect to the number of shares of Class A Common Stock subject to such options or warrants and the exercise prices thereof. The impact of this change in capital structure has been retrospectively applied to all periods presented herein. Common Stock and Series B Preferred Stock The Company had the following transactions in its common stock during the six months ended June 30, 2023: • In April 2023, a shareholder converted 162,500 shares of Class B common stock into 162,500 shares of Class A common stock. • In May 2023, the Company issued 13,750 restricted shares of Class A Common Stock as additional consideration for the purchase of the convertible note and 196,250 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. • In June 2023, the Company issued 67,400 restricted shares of Class A Common Stock as additional consideration for the purchase of the convertible note and 1,200,000 restricted shares of Class A Common Stock, which shall be returned to the Company if timely repayments are made against the note. Series B Preferred Stock During April 2023, a shareholder converted 1 share of Series B preferred stock into 1 share of Class A common stock. Stock Options The following summarizes the stock option activity for the six months ended June 30, 2023: Options Weighted Weighted Aggregate Outstanding at December 31, 2022 386,751 $ 4.39 7.94 $ 463,495 Granted — — Forfeited (16,844) 6.16 Exercised — — Outstanding at June 30, 2023 369,907 $ 4.31 7.38 $ 193,492 Exercisable at June 30, 2023 159,001 $ 1.85 5.46 $ 193,492 The following table summarizes information about options outstanding and exercisable as of June 30, 2023: Options Outstanding Options Exercisable Exercise Number Weighted Weighted Number Weighted $ 0.40 111,438 5.01 $ 0.40 111,438 $ 0.40 0.80 10,625 4.78 0.80 10,625 0.80 6.16 234,340 8.84 6.16 23,434 6.16 7.20 13,504 3.77 7.20 13,504 7.20 369,907 159,001 During the six months ended June 30, 2023 and 2022, stock option expense amounted to $0.3 million and $0.5 million, respectively. Unrecognized stock option expense as of June 30, 2023, amounted to $0.8 million, which will be recognized over a period extending through April 2025. Warrants The following summarizes the warrants activity for the six months ended June 30, 2023: Warrants Weighted Weighted Aggregate Outstanding at December 31, 2022 2,321,411 $ 11.78 4.31 $ — Granted 203,579 3.51 5.00 Forfeited — — Exercised — — Outstanding at June 30, 2023 2,524,990 $ 11.12 3.87 $ — Exercisable at June 30, 2023 2,524,990 $ 11.12 3.87 $ — The following table summarizes information about warrants outstanding and exercisable as of June 30, 2023: Warrants Outstanding Warrants Exercisable Exercise Number Weighted Weighted Number Weighted $ 52.80 52,084 1.64 $ 52.80 52,084 $ 52.80 20.16 49,604 1.45 20.16 49,604 20.16 24.80 535,716 3.41 24.80 535,716 24.80 24.64 53,572 3.40 24.64 53,572 24.64 5.52 1,630,435 4.04 5.52 1,630,435 5.52 3.50 200,000 5.00 3.50 200,000 3.50 4.20 3,579 5.00 4.20 3,579 4.20 2,524,990 2,524,990 During the six months ended June 30, 2023, the Company issued 200,000 and 3,579 warrants to two holders in connection with the issuance of a convertible note payable. The warrants have an exercise price of $3.50 and $4.20, respectively, were exercisable as of June 29, 2023 and expire on June 29, 2028. The fair value of the 200,000 and 3,579 warrants issued is $378,000 and $6,764, respectively, and was determined using the Black-Scholes option pricing model. The fair value of the warrants was determined using the following assumptions: Stock price $1.89 Risk-free interest rate 4.50% Expected life of the warrants 2.5 Expected volatility 1242% Expected dividend yield 0% |
Segment Reporting
Segment Reporting | 6 Months Ended |
Jun. 30, 2023 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment ReportingThe Company discloses segment information that is consistent with the way in which management operates and views its business. Effective during the quarter ended September 30, 2022, the Company increased its reportable segments to eight segments. All segments and the subsidiaries within each segment are geographically located in North America. The financial results are logical to review in this manner for comparison, trend, deviations, etc. purposes. Management excludes the following when reviewing the profit/loss by segment. • Intercompany Sales/COGS • Management fees to the parent Company • Income tax benefit/expense There has not been any change to the measurement method in how management reviews the profit/loss by segment. The operating segments and their business activity are as follows: • A4 Construction Services - MSM provides commercial construction services primarily as a sheet metal contractor. • A4 Construction Services - Excel provides commercial construction services primarily as a sheet metal contractor. • A4 Manufacturing - QCA is a contract manufacturer within the technology industry. • A4 Manufacturing - Alt Labs is a contract manufacturer within the dietary & nutraceutical supplements industry. • A4 Defense - TDI does contracting for the US Government particularly for the US Defense Department and US Department of State. • A4 Technologies - RCA is a business-to-business ("B2B") commercial electronics manufacturer. • A4 Technologies - Elecjet is a battery research and development company. • A4 Aerospace - Vayu is a drone aircraft manufacturer. • A4 All Other includes the QCA-C, IDT, GAC, and Corporate. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenue A4 Construction Services - MSM $ 3,550,392 $ 5,326,296 $ 7,363,532 $ 9,093,686 A4 Construction Services - Excel 110,494 342,963 443,358 631,777 A4 Manufacturing - QCA 5,319,687 4,241,382 9,511,330 8,560,242 A4 Manufacturing - Alt Labs 6,787,129 2,958,885 11,014,043 6,783,023 A4 Defense - TDI 2,413,363 2,472,207 5,383,450 5,160,188 A4 Technologies - RCA 8,538,620 8,910,276 15,992,043 18,147,535 A4 Technologies - Elecjet 121,845 345,382 224,340 902,111 A4 Aerospace - Vayu 4,171 — 4,171 25,000 All Other 1,176,325 673,735 2,447,472 1,559,718 $ 28,022,026 $ 25,271,126 $ 52,383,739 $ 50,863,280 Gross profit (loss) A4 Construction Services - MSM $ 549,807 $ 191,788 $ 781,695 $ 655,594 A4 Construction Services - Excel (373,950) (26,468) (523,958) (125,442) A4 Manufacturing - QCA 1,786,189 1,149,049 2,683,904 2,176,233 A4 Manufacturing - Alt Labs 1,778,676 857,997 2,727,428 1,759,476 A4 Defense - TDI 944,550 1,285,732 1,561,132 2,128,921 A4 Technologies - RCA 2,752,026 2,159,923 5,126,204 4,344,251 A4 Technologies - Elecjet (53,000) 249,297 (126,809) 187,268 A4 Aerospace - Vayu 4,116 — 1,706 25,000 All Other 398,676 293,225 772,244 646,699 $ 7,787,090 $ 6,160,543 $ 13,003,546 $ 11,798,000 Income (loss) from operations A4 Construction Services - MSM $ (150,608) $ (152,882) $ (555,021) $ (468,580) A4 Construction Services - Excel (578,989) (238,956) (1,011,070) (558,946) A4 Manufacturing - QCA 446,516 270,804 465,613 685,252 A4 Manufacturing - Alt Labs 181,351 5,190,788 (377,774) 4,203,305 A4 Defense - TDI 829,235 783,704 1,010,769 1,206,844 A4 Technologies - RCA 944,686 193,377 1,420,550 759,667 A4 Technologies - Elecjet (222,275) (268,554) (467,696) (572,900) A4 Aerospace - Vayu (1,380,016) (819,431) (2,200,983) (1,626,328) All Other (3,788,794) (2,587,090) (7,143,755) (5,012,709) $ (3,718,894) $ 2,371,760 $ (8,859,367) $ (1,384,395) Depreciation and amortization A4 Construction Services - MSM $ 178,665 $ 171,342 $ 352,963 $ 337,746 A4 Construction Services - Excel 67,524 132,917 135,049 132,917 A4 Manufacturing - QCA 113,673 108,304 230,552 208,783 A4 Manufacturing - Alt Labs 225,654 253,948 434,208 560,983 A4 Defense - TDI 72,433 72,090 144,866 144,180 A4 Technologies - RCA 244,805 170,053 489,609 340,099 A4 Technologies - Elecjet 105,668 103,633 211,334 205,133 A4 Aerospace - Vayu 259,679 259,225 518,590 533,894 All Other 317,255 277,280 595,968 554,721 $ 1,585,356 $ 1,548,792 $ 3,113,139 $ 3,018,456 Interest expense A4 Construction Services - MSM $ 98,163 $ 124,220 $ 211,873 $ 227,245 A4 Construction Services - Excel 60,196 61,643 120,766 123,628 A4 Manufacturing - QCA 171,005 87,601 334,650 123,890 A4 Manufacturing - Alt Labs 84,979 94,561 149,659 151,677 A4 Defense - TDI 16,598 — 33,945 — A4 Technologies - RCA 71,896 60,431 157,852 115,248 A4 Technologies - Elecjet — — — — A4 Aerospace - Vayu 5,414 — 11,372 — All Other 600,494 534,018 1,087,498 829,747 $ 1,108,745 $ 962,474 $ 2,107,615 $ 1,571,435 Net income (loss) A4 Construction Services - MSM $ (248,771) $ (276,934) $ (729,371) $ (639,301) A4 Construction Services - Excel (639,185) (300,599) (1,131,836) (682,574) A4 Manufacturing - QCA 275,944 161,763 131,757 535,630 A4 Manufacturing - Alt Labs 178,697 5,298,191 (480,059) 4,186,729 A4 Defense - TDI 837,719 783,704 1,001,906 1,206,844 A4 Technologies - RCA 872,790 132,946 1,262,698 644,419 A4 Technologies - Elecjet (222,275) (272,099) (467,696) (576,445) A4 Aerospace - Vayu (1,414,806) (819,431) (2,241,731) (1,626,328) All Other (4,191,979) (3,167,735) (7,666,677) (5,508,728) $ (4,551,866) $ 1,539,806 $ (10,321,009) $ (2,459,754) The Company’s reportable segments as of June 30, 2023, and December 31, 2022, were as follows: As of June 30, 2023 As of December 31, 2022 Total assets A4 Construction Services - MSM $ 10,675,363 $ 11,309,049 A4 Construction Services - Excel 3,334,543 3,359,818 A4 Manufacturing - QCA 20,550,261 20,988,492 A4 Manufacturing - Alt Labs 28,335,277 26,636,905 A4 Defense - TDI 13,663,378 13,497,381 A4 Technologies - RCA 24,753,925 27,191,977 A4 Technologies - Elecjet 12,787,943 12,897,440 A4 Aerospace - Vayu 12,890,586 14,632,530 All Other 15,619,649 15,118,622 $ 142,610,925 $ 145,632,214 Goodwill A4 Construction Services - MSM $ 113,592 $ 113,592 A4 Construction Services - Excel — — A4 Manufacturing - QCA 1,963,761 1,963,761 A4 Manufacturing - Alt Labs 4,410,564 4,410,564 A4 Defense - TDI 6,426,786 6,426,786 A4 Technologies - RCA 1,355,728 1,355,728 A4 Technologies - Elecjet 6,496,343 6,496,343 A4 Aerospace - Vayu — — All Other 1,913,310 1,913,310 $ 22,680,084 $ 22,680,084 Accounts receivable, net A4 Construction Services - MSM $ 4,373,429 $ 5,188,521 A4 Construction Services - Excel 386,429 288,243 A4 Manufacturing - QCA 2,768,483 3,867,141 A4 Manufacturing - Alt Labs 2,458,636 1,833,502 A4 Defense - TDI 2,207,665 1,905,314 A4 Technologies - RCA 3,669,480 3,232,559 A4 Technologies - Elecjet 6,302 12,888 A4 Aerospace - Vayu — — All Other 758,324 811,776 $ 16,628,748 $ 17,139,944 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Licensing Agreement DTI has entered into licensing agreements with RCA Trademark Management for the licensing rights to the respective trademarks in the United States of America and Canada. The RCA licensing agreement was amended with Technicolor, S.A., as licensor, and expires December 31, 2027 except for the agreement relating to Computer Monitors and Outdoor Televisions which expires on December 31, 2025. DTI agreed to pay a royalty fee of 2.50% - 3.50% on net sales based on product type with a total minimum annual payment of $550,000 for the year ended 2023, $600,000 for the year ended 2024, $620,000 for the year ended 2025, $660,000 for the year ended 2026, and $700,000 for the year ended 2027. Warranty Service Agreement DTI entered into a warranty service agreement to provide certain warranty services for a lighting supplier through December 31, 2024, except for one class of customer, for whom services will be provided through 2030. In exchange for these services, DTI expects to receive $66,626 and $59,964 during the years ended December 31, 2023 and 2024, respectively. Royalty Agreement On November 28, 2021, the Company entered into a Royalty Agreement with the sellers of Elecjet. Upon closing the Company desires to build its initial factory (“Factory”) to manufacture graphene batteries in the territory of the United States. The Company agrees to pay the sellers 1.5% of net sales for batteries produced by the Factory. Royalty payments shall continue to be paid for a period of ten years from the starting date, or until the total of the royalty payments equals $50 million, whichever occurs first. Legal Proceedings From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business. Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows. Alan Martin Lawsuit In August 2020, in a matter relating to our former subsidiary Horizon Well Testing, LLC (“Horizon”), the Company filed a lawsuit in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon dba Venture West Energy Services, LLC (“VWES”). The Company brought suit seeking to avoid the claimed liability due from the Company to Alan Martin, for the Company’s 2017 purchase of Mr. Martin’s business, Horizon. On summary judgment, the court found that the Company’s claim was barred by a time-limiting clause for indemnification claims. The Company disagreed with the court’s ruling and planned to appeal. Mr. Martin filed a counterclaim in which he claimed that he remains unpaid on the promissory note, as modified, under which the Company purchased Horizon. The note balance alleged to have a principal sum due of $3.3 million, plus interest at 8% accruing from 2019 to present, plus late fees accruing at $575 per day. After confidential mediation before Hon. Eileen Willett, United States Magistrate Judge for the United States District Court for the District of Arizona, the parties settled their dispute on acceptable terms. The Company and Mr. Martin agreed to a settlement agreement whereby Mr. Martin will receive the following: $100,000 payable on or before August 3, 2023; 250,000 shares issued immediately; $2,000,000 payable on or before October 31, 2023 and a $1,800,000 note payable with monthly payments of $75,000 beginning on December 1, 2023 with a final payment of $900,000 payable on or before December 1, 2024. The $100,000 payment and the 250,000 shares have been paid and issued by the Company. Robert Porter Lawsuit In August 2021, in a matter relating to Horizon, Robert Porter filed a lawsuit in the District Court of Oklahoma County, State of Oklahoma (CJ-2021-3421), alleging unjust enrichment and breach of contract with respect to shares of Company that Mr. Porter claims were owed to him pursuant to his employment contract with the Company as President of Horizon. In October 2021, the Company filed its answer denying such claims. In October 2021, the Company also filed counterclaims against Mr. Porter for conversion and breach of fiduciary duties. The Company believes this is a frivolous lawsuit and as such, no accrual has been recorded as of June 30, 2023, and December 31, 2022. VWES Lawsuit In October 2021, in a matter relating to Horizon, the Company received three complaints in the District Court of Oklahoma Country State of Oklahoma from former VWES employees Bruce Morse (CJ-2021-4316), Brian Hobbs (CJ-2021-4315), Thomas Karraker (CJ-2021-4314) for unjust enrichment, and breach of contract with respect to their employment contracts with Horizon. On January 19, 2022, the Company filed answers to all three lawsuits that denied these claims. The Company believes these are frivolous lawsuits. In July 2022, the Company and Mr. Morse settled his claims against the Company. The settlement included the cash payment of $24,375 for Mr. Morse's claimed 4,688 shares of Class A common stock, and subsequently Mr. Morse’s case has been dismissed. Subsequently, Mr. Hobbs and Mr. Karraker have also expressed interest in settling claims on similar terms, and negotiations were ongoing as of the date of this report. As no formal settlement offer has been extended, no accrual has been recorded as of June 30, 2023, and December 31, 2022. Gatehouse Lawsuit In June 2022, in a matter relating to the Company’s subsidiaries, DTI Services Limited Liability Company and Direct Tech Sales, LLC (doing business as RCA, the Company received a complaint filed in the Superior Court of Marion County State of Indiana (CAUSE NO. 49D01-2203-PL-006662) by Gatehouse, LLC (“Gatehouse”), a supplier of PPP gloves for resale by RCA, seeking payment of $213,000 for supplied goods that RCA has good reason to believe are counterfeit, and thus unsalable. RCA has answered the complaint and asserted counterclaims of fraud and breach of contract. After a long delay in prosecution of the case by Gatehouse, motion practice has begun in this matter. However no scheduling, hearings, or trial date had been set as of the date of this report. Mark Bell Lawsuit In November 2022, the Company, and its subsidiaries Excel and A4 Construction, received a complaint filed by Mark Bell in the district court of Idaho (CV42-22-4066) with regard to the Company’s February 2020 purchase of Excel Fabrication LLC (“Excel”) from Mr. Bell. The matter relates to the lack of payment on a $2.3 million seller note comprising part of the purchase consideration. In December 2022 the Company counter-sued Mr. Bell for breach of contract, fraud, and misrepresentation in the February 2020 sale of Excel to the Company. The case is set for trial in June of 2024. Starr Corporation Arbitration In December 2022, the Company’s subsidiary Excel received a demand for binding arbitration (AAA Case No. 01-22-0004-9935) by Starr Corporation of Idaho (“Starr Corporation”), a contractor for whom Excel was performing as sub-contractor. Excel stopped its work for Starr Corporation' pursuant to its claimed contract right of termination based on Starr Corporation’s failure to make payment within the contracted period for work satisfactorily performed. Starr Corporation claims that Excel’s termination was wrongful, and seeks approximately $0.5 million, reflecting its costs in having to complete work that was called for under the contract. Excel is seeking a determination that its termination was rightful under the terms of the contract, and in addition seeks payment on its unpaid billing submittals and additional costs. Arbitration hearings are scheduled to commence in April 2024. As no formal settlement offer has been extended, no accrual has been recorded as of June 30, 2023, and December 31, 2022. State University of New York at Stonybrook Lawsuit In February 2023, the Company was apprised that a complaint was brought in the State of New York against Vayu in 2019 (prior to the Company’s ownership of Vayu) seeking a refund for two returned airframes. The case had originally been dismissed for lack of jurisdiction but was revived by virtue of New York’s highest court ruling (State of New York v Vayu, APL-2021-00148) that the State’s long arm statute applied to the 2016 transaction between Vayu and the State University of New York at Stonybrook. Total damages sought by the State of New York are less than $100,000, including interest and costs. In light of the decision by the Court of Appeals to return the case to the trial courts for adjudication, and as of the date of this report the Company and the State of New York have begun informal settlement discussions including the possibility of the State providing information useful to the Company should it wish to subsequently seek redress from the previous owners of Vayu. Kevin Thomas Lawsuit In May 2023, Kevin Thomas, who sold Alternative Laboratories, LLC to the Company in May of 2021, sued the Company, and its subsidiaries Alt Labs and A4 Manufacturing, in the State circuit court for Collier County Florida (Case Number 23-CA-1981), alleging that the Company failed to deliver shares of the Company as promised by the terms of the purchase agreement. Additionally Mr. Thomas claimed that an amount of $610,000 in Employee Retention Credits was received by the Company and that portion representing the credit attributed to the first and second quarters of 2021 (prior to the May 4th, 2021 date of sale), should be remitted to him rather than retained by the Company. The Company believes that Mr. Thomas’ complaint is wholly without merit, and as of the date of this report, the Company was in the process of answering the complaint and considering possible motions and counterclaims. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events In July 2023, Vayu received its first purchase order from All American Contracting for ten G1 MKIII Fixed Wing unmanned aerial vehicles ("UAVs") for $5.25 million with delivery expected to occur in Q4 2023 or Q1 2024. The purchase order requires a 10% down payment, with final payment to be sent prior to taking delivery. In July 2023, Morris entered into an Amended Forbearance agreement extending the forbearance period until August 31, 2023. On July 31, 2023, the Company and Mr. Martin agreed to a settlement agreement whereby Mr. Martin will receive the following: $100,000 payable on or before August 3, 2023; 250,000 shares issued immediately; $2,000,000 payable on or before October 31, 2023 and a $1,800,000 note payable with monthly payments of $75,000 beginning on December 1, 2023 with a final payment of $900,000 payable on or before December 1, 2024. The $100,000 payment and the 250,000 shares have been paid and issued by the Company. On August 4, 2023, the Company filed a Registration Statement on Form S-1 with the Securities and Exchange Commission ("SEC") relating to a proposed offering of our Class A common stock. The number of shares of Class A common stock to be offered and the price for the proposed offering will be determined at the time of pricing and may be at a discount to the then current market price. The offering is subject to market conditions, and the proceeds will be utilized for general corporate purposes, working capital, research and development, and repayment of certain outstanding debt. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of presentation | The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Certain reclassifications have been made that have no impact on net earnings and financial position. |
Principles of consolidation | The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of June 30, 2023, and December 31, 2022. Significant intercompany balances and transactions have been eliminated. |
Use of estimates | The consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. This applies in particular to useful lives of long-lived assets, reserves for accounts receivable and inventory, valuation allowance for deferred tax assets, fair values assigned to intangible assets acquired, and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. |
Cash | Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. |
Major customers & vendors | Major Customers & Vendors The Company had no customers which made up over 10% of total Company accounts receivable as of June 30, 2023, or December 31, 2022. For the six months ended June 30, 2023, the Company had no customers which made up over 10% of total Company revenues. For the six months ended June 30, 2022, the Company had one customer within the A4 Technology - RCA segment, which made up 12% of total Company revenues. For the six months ended June 30, 2023 and 2022, the Company received 10% and 10%, respectively, of total Company revenues from prime contractors. For the six months ended June 30, 2023, the Company had no vendors, which made up over 10% of total Company purchases. For the six months ended June 30, 2022, the Company had one vendor within the A4 Technology - RCA segment, which made up 17% of total Company purchases. |
Inventory | Inventory for all subsidiaries is valued at weighted average cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower. Inventory is segregated into three areas, raw materials, work-in-process and finished goods. |
Impairment of Long-Lived Assets | The Company accounts for long-lived assets in accordance with the provisions of ASC Topic 360, Accounting for the Impairment of Long-Lived Assets. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when the estimated future cash flows from the use of the asset is less than the carrying amount of that asset. During the six months ended June 30, 2023, there were no events or changes in circumstances that indicated a quantitative impairment analysis was necessary and as such, no impairment was recorded. |
Goodwill | In financial reporting, goodwill is not amortized, but is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Events that result in an impairment review include significant changes in the business climate, declines in our operating results, or an expectation that the carrying amount may not be recoverable. We assess potential impairment by considering present economic conditions as well as future expectations. All assessments of goodwill impairment are conducted at the individual reporting unit level. As of June 30, 2023, and December 31, 2022, the reporting units with goodwill were QCA, MSM, Alt Labs, TDI, IDT, Elecjet, and RCA. Consistent with our prior year assessment, the Elecjet reporting unit is considered an at-risk reporting unit. Our methods and assumptions were consistent with those discussed below in the Fair Value Measurement subsection. This reporting unit is primarily considered at-risk as it is a start-up subsidiary with minimal to no revenue to offset its research & development expenses. The DCF model includes revenue growth assumptions of us executing large new customer and/or supplier agreements within the next two years and then steadily increasing revenue at a more normalized rate thereafter. Any failure to execute these customer and/or supplier arrangements would negatively impact the key growth assumptions. |
Fair value measurements | ASC") 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. We apply the provisions of fair value measurement to various nonrecurring measurements for our financial and nonfinancial assets and liabilities. The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. We calculate the estimated fair value of a reporting unit using a combination of the income and market approaches. For the income approach, we use a discounted cash flow models developed in connection with our third-party valuation specialists that include the following assumptions, among others: projections of revenues, expenses, and related cash flows based on assumed long-term growth rates; and estimated discount rates. For the market approach, we use analyses based primarily on market comparables. We base these assumptions on historical data and experience, industry projections, and general economic conditions. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of June 30, 2023, and December 31, 2022, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis, as all of our financial assets and liabilities were Level 1. |
Equity Method Investments | In February 2023, the Company made a $0.3 million investment for a 10% equity interest in a battery materials company, which includes a seat on its board of directors, and participation rights in future funding rounds. The investment is accounted for as an equity method investment as the board representation allows us to have significant influence over the operating and financial policies of the battery materials company. The investment is presented in other non-current assets on the consolidated balance sheet with the value of the investment being adjusted in arrears on a quarterly basis based on its financial performance. In June 2023, a subsequent funding round was held, in which the Company waived its participation rights, that decreased our equity investment to an 8% equity interest. |
Research and Development | The Company focuses on quality control and development of new products and the improvement of existing products. All costs related to research and development activities are expensed as incurred. |
Earnings (loss) per share | The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The amount of anti-dilutive shares related to stock options and warrants as of June 30, 2023 and 2022 was 2,894,897 and 1,098,050. respectively. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) inclusive of all classes of common stock as the only difference between the classes of common stock are related to the voting rights for the three and six months ended June 30, 2023 and 2022: For the Three Months Ended June 30, 2023 For the Three Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Income Shares Per Share Amount Basic EPS Net income (loss) $ (4,551,866) 25,103,271 $ (0.18) $ 1,539,806 22,899,822 $ 0.07 Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (4,551,866) $ 25,103,271 $ (0.18) $ 1,539,806 $ 22,899,822 $ 0.07 For the Six Months Ended June 30, 2023 For the Six Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS Net loss $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) |
Revenue Recognition | The Company recognizes revenue under ASC Topic 606, Revenue from contract with Customers ("Topic 606"). The following is a summary of the revenue recognition policy for each of the Company’s subsidiaries. Revenue is recognized under Topic 606, at a point in time and over a period of time, in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements: – executed contract with the Company's customers that it believes are legally enforceable; – identification of performance obligations in the respective contract; – determination of the transaction price for each performance obligation in the respective contract; – allocation of the transaction price to each performance obligation; and – recognition of revenue only when the Company satisfies each performance obligation. The following tables presents our revenues disaggregated by type for the three months ended June 30, 2023 and 2022: Three Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 12,886,116 $ — $ 8,660,465 $ — $ 21,546,581 Sale of services 3,660,886 — 2,413,363 — 401,196 6,475,445 Total revenues $ 3,660,886 $ 12,886,116 $ 2,413,363 $ 8,660,465 $ 401,196 $ 28,022,026 Three Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 7,530,475 $ — $ 9,255,658 $ — $ 16,786,133 Sale of services 5,669,259 — 2,472,207 — 343,527 8,484,993 Total revenues $ 5,669,259 $ 7,530,475 $ 2,472,207 $ 9,255,658 $ 343,527 $ 25,271,126 The following tables presents our revenues disaggregated by type for the six months ended June 30, 2023 and 2022: Six Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 22,206,937 $ — $ 16,216,383 $ — $ 38,423,320 Sale of services 7,806,890 — 5,383,450 — 770,079 13,960,419 Total revenues $ 7,806,890 $ 22,206,937 $ 5,383,450 $ 16,216,383 $ 770,079 $ 52,383,739 Six Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 16,178,570 $ — $ 19,049,646 $ — $ 35,228,216 Sale of services 9,725,463 — 5,160,188 — 749,413 15,635,064 Total revenues $ 9,725,463 $ 16,178,570 $ 5,160,188 $ 19,049,646 $ 749,413 $ 50,863,280 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Inventory | Inventory at June 30, 2023, and December 31, 2022, consisted of: June 30, 2023 December 31, 2022 Raw materials $ 9,726,538 $ 9,116,824 Work in process 3,528,187 3,165,876 Finished goods 10,764,288 12,975,669 Inventory $ 24,019,013 $ 25,258,369 |
Schedule of Computation of Basic and Diluted EPS | The following table illustrates the computation of basic and diluted earnings per share (“EPS”) inclusive of all classes of common stock as the only difference between the classes of common stock are related to the voting rights for the three and six months ended June 30, 2023 and 2022: For the Three Months Ended June 30, 2023 For the Three Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Income Shares Per Share Amount Basic EPS Net income (loss) $ (4,551,866) 25,103,271 $ (0.18) $ 1,539,806 22,899,822 $ 0.07 Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (4,551,866) $ 25,103,271 $ (0.18) $ 1,539,806 $ 22,899,822 $ 0.07 For the Six Months Ended June 30, 2023 For the Six Months Ended June 30, 2022 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS Net loss $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) Effect of Dilutive Securities Stock options and warrants — — — — — — Dilute EPS Total $ (10,321,009) 25,076,452 $ (0.41) $ (2,459,754) 22,890,560 $ (0.11) |
Disaggregation of Revenue | The following tables presents our revenues disaggregated by type for the three months ended June 30, 2023 and 2022: Three Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 12,886,116 $ — $ 8,660,465 $ — $ 21,546,581 Sale of services 3,660,886 — 2,413,363 — 401,196 6,475,445 Total revenues $ 3,660,886 $ 12,886,116 $ 2,413,363 $ 8,660,465 $ 401,196 $ 28,022,026 Three Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 7,530,475 $ — $ 9,255,658 $ — $ 16,786,133 Sale of services 5,669,259 — 2,472,207 — 343,527 8,484,993 Total revenues $ 5,669,259 $ 7,530,475 $ 2,472,207 $ 9,255,658 $ 343,527 $ 25,271,126 The following tables presents our revenues disaggregated by type for the six months ended June 30, 2023 and 2022: Six Months Ended June 30, 2023 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 22,206,937 $ — $ 16,216,383 $ — $ 38,423,320 Sale of services 7,806,890 — 5,383,450 — 770,079 13,960,419 Total revenues $ 7,806,890 $ 22,206,937 $ 5,383,450 $ 16,216,383 $ 770,079 $ 52,383,739 Six Months Ended June 30, 2022 Construction Services Manufacturing Defense Technologies Aerospace Total Sale of goods $ — $ 16,178,570 $ — $ 19,049,646 $ — $ 35,228,216 Sale of services 9,725,463 — 5,160,188 — 749,413 15,635,064 Total revenues $ 9,725,463 $ 16,178,570 $ 5,160,188 $ 19,049,646 $ 749,413 $ 50,863,280 |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Leases [Abstract] | |
Finance Lease, Liability, Fiscal Year Maturity | As of June 30, 2023, the future minimum finance and operating lease payments were as follows: Twelve Months Ending June 30, Finance Operating 2024 $ 1,938,360 $ 2,412,039 2025 1,944,246 2,304,494 2026 1,848,756 1,784,228 2027 1,890,900 1,823,449 2028 1,932,830 1,646,961 Thereafter 13,879,717 12,457,744 Total payments 23,434,809 22,428,915 Less: imputed interest (8,474,940) (6,462,880) Total obligation 14,959,869 15,966,035 Less: current portion (764,267) (1,518,842) Non-current financing leases obligations $ 14,195,602 $ 14,447,193 |
Lessee, Operating Lease, Liability, Maturity | As of June 30, 2023, the future minimum finance and operating lease payments were as follows: Twelve Months Ending June 30, Finance Operating 2024 $ 1,938,360 $ 2,412,039 2025 1,944,246 2,304,494 2026 1,848,756 1,784,228 2027 1,890,900 1,823,449 2028 1,932,830 1,646,961 Thereafter 13,879,717 12,457,744 Total payments 23,434,809 22,428,915 Less: imputed interest (8,474,940) (6,462,880) Total obligation 14,959,869 15,966,035 Less: current portion (764,267) (1,518,842) Non-current financing leases obligations $ 14,195,602 $ 14,447,193 |
Schedule of Right of Use Assets and Lease Liabilities | The table below presents the operating lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of June 30, 2023, and December 31, 2022: June 30, December 31, Assets Operating lease assets Operating lease right of use assets $ 15,704,511 $ 16,407,566 Total lease assets $ 15,704,511 $ 16,407,566 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 1,518,842 $ 1,318,885 Noncurrent liabilities Operating lease liability Long-term operating lease liability 14,447,193 15,262,494 Total lease liability $ 15,966,035 $ 16,581,379 |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Notes Payable | The outstanding balances for the loans as of June 30, 2023, and December 31, 2022, were as follows: June 30, December 31, Lines of credit, current portion $ 8,699,609 $ 7,426,814 Equipment loans, current portion 76,072 68,410 Related party term notes, current portion 555,000 — Term notes, current portion 6,094,400 3,132,726 Total current 15,425,081 10,627,950 Lines of credit, net of current portion 4,058,411 7,215,520 Long-term portion of equipment loans and term notes 2,144,048 4,266,350 Total notes payable and lines of credit $ 21,627,540 $ 22,109,820 |
Schedule of Maturities of Long-term Debt | Future scheduled maturities of outstanding debt are as follows: Twelve Months Ending June 30, 2024 $ 15,425,081 2025 1,743,815 2026 669,034 2027 123,428 2028 3,594,396 Thereafter 71,786 Total $ 21,627,540 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Equity [Abstract] | |
Share-based Payment Arrangement, Option, Activity | The following summarizes the stock option activity for the six months ended June 30, 2023: Options Weighted Weighted Aggregate Outstanding at December 31, 2022 386,751 $ 4.39 7.94 $ 463,495 Granted — — Forfeited (16,844) 6.16 Exercised — — Outstanding at June 30, 2023 369,907 $ 4.31 7.38 $ 193,492 Exercisable at June 30, 2023 159,001 $ 1.85 5.46 $ 193,492 |
Share-based Payment Arrangement, Option, Exercise Price Range | The following table summarizes information about options outstanding and exercisable as of June 30, 2023: Options Outstanding Options Exercisable Exercise Number Weighted Weighted Number Weighted $ 0.40 111,438 5.01 $ 0.40 111,438 $ 0.40 0.80 10,625 4.78 0.80 10,625 0.80 6.16 234,340 8.84 6.16 23,434 6.16 7.20 13,504 3.77 7.20 13,504 7.20 369,907 159,001 |
Schedule of Stockholders' Equity Note, Warrants or Rights | The following summarizes the warrants activity for the six months ended June 30, 2023: Warrants Weighted Weighted Aggregate Outstanding at December 31, 2022 2,321,411 $ 11.78 4.31 $ — Granted 203,579 3.51 5.00 Forfeited — — Exercised — — Outstanding at June 30, 2023 2,524,990 $ 11.12 3.87 $ — Exercisable at June 30, 2023 2,524,990 $ 11.12 3.87 $ — |
Schedule of Warrants Outstanding and Exercisable | The following table summarizes information about warrants outstanding and exercisable as of June 30, 2023: Warrants Outstanding Warrants Exercisable Exercise Number Weighted Weighted Number Weighted $ 52.80 52,084 1.64 $ 52.80 52,084 $ 52.80 20.16 49,604 1.45 20.16 49,604 20.16 24.80 535,716 3.41 24.80 535,716 24.80 24.64 53,572 3.40 24.64 53,572 24.64 5.52 1,630,435 4.04 5.52 1,630,435 5.52 3.50 200,000 5.00 3.50 200,000 3.50 4.20 3,579 5.00 4.20 3,579 4.20 2,524,990 2,524,990 |
Fair Value Measurement Inputs and Valuation Techniques | The fair value of the warrants was determined using the following assumptions: Stock price $1.89 Risk-free interest rate 4.50% Expected life of the warrants 2.5 Expected volatility 1242% Expected dividend yield 0% |
Segment Reporting (Tables)
Segment Reporting (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment | Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenue A4 Construction Services - MSM $ 3,550,392 $ 5,326,296 $ 7,363,532 $ 9,093,686 A4 Construction Services - Excel 110,494 342,963 443,358 631,777 A4 Manufacturing - QCA 5,319,687 4,241,382 9,511,330 8,560,242 A4 Manufacturing - Alt Labs 6,787,129 2,958,885 11,014,043 6,783,023 A4 Defense - TDI 2,413,363 2,472,207 5,383,450 5,160,188 A4 Technologies - RCA 8,538,620 8,910,276 15,992,043 18,147,535 A4 Technologies - Elecjet 121,845 345,382 224,340 902,111 A4 Aerospace - Vayu 4,171 — 4,171 25,000 All Other 1,176,325 673,735 2,447,472 1,559,718 $ 28,022,026 $ 25,271,126 $ 52,383,739 $ 50,863,280 Gross profit (loss) A4 Construction Services - MSM $ 549,807 $ 191,788 $ 781,695 $ 655,594 A4 Construction Services - Excel (373,950) (26,468) (523,958) (125,442) A4 Manufacturing - QCA 1,786,189 1,149,049 2,683,904 2,176,233 A4 Manufacturing - Alt Labs 1,778,676 857,997 2,727,428 1,759,476 A4 Defense - TDI 944,550 1,285,732 1,561,132 2,128,921 A4 Technologies - RCA 2,752,026 2,159,923 5,126,204 4,344,251 A4 Technologies - Elecjet (53,000) 249,297 (126,809) 187,268 A4 Aerospace - Vayu 4,116 — 1,706 25,000 All Other 398,676 293,225 772,244 646,699 $ 7,787,090 $ 6,160,543 $ 13,003,546 $ 11,798,000 Income (loss) from operations A4 Construction Services - MSM $ (150,608) $ (152,882) $ (555,021) $ (468,580) A4 Construction Services - Excel (578,989) (238,956) (1,011,070) (558,946) A4 Manufacturing - QCA 446,516 270,804 465,613 685,252 A4 Manufacturing - Alt Labs 181,351 5,190,788 (377,774) 4,203,305 A4 Defense - TDI 829,235 783,704 1,010,769 1,206,844 A4 Technologies - RCA 944,686 193,377 1,420,550 759,667 A4 Technologies - Elecjet (222,275) (268,554) (467,696) (572,900) A4 Aerospace - Vayu (1,380,016) (819,431) (2,200,983) (1,626,328) All Other (3,788,794) (2,587,090) (7,143,755) (5,012,709) $ (3,718,894) $ 2,371,760 $ (8,859,367) $ (1,384,395) Depreciation and amortization A4 Construction Services - MSM $ 178,665 $ 171,342 $ 352,963 $ 337,746 A4 Construction Services - Excel 67,524 132,917 135,049 132,917 A4 Manufacturing - QCA 113,673 108,304 230,552 208,783 A4 Manufacturing - Alt Labs 225,654 253,948 434,208 560,983 A4 Defense - TDI 72,433 72,090 144,866 144,180 A4 Technologies - RCA 244,805 170,053 489,609 340,099 A4 Technologies - Elecjet 105,668 103,633 211,334 205,133 A4 Aerospace - Vayu 259,679 259,225 518,590 533,894 All Other 317,255 277,280 595,968 554,721 $ 1,585,356 $ 1,548,792 $ 3,113,139 $ 3,018,456 Interest expense A4 Construction Services - MSM $ 98,163 $ 124,220 $ 211,873 $ 227,245 A4 Construction Services - Excel 60,196 61,643 120,766 123,628 A4 Manufacturing - QCA 171,005 87,601 334,650 123,890 A4 Manufacturing - Alt Labs 84,979 94,561 149,659 151,677 A4 Defense - TDI 16,598 — 33,945 — A4 Technologies - RCA 71,896 60,431 157,852 115,248 A4 Technologies - Elecjet — — — — A4 Aerospace - Vayu 5,414 — 11,372 — All Other 600,494 534,018 1,087,498 829,747 $ 1,108,745 $ 962,474 $ 2,107,615 $ 1,571,435 Net income (loss) A4 Construction Services - MSM $ (248,771) $ (276,934) $ (729,371) $ (639,301) A4 Construction Services - Excel (639,185) (300,599) (1,131,836) (682,574) A4 Manufacturing - QCA 275,944 161,763 131,757 535,630 A4 Manufacturing - Alt Labs 178,697 5,298,191 (480,059) 4,186,729 A4 Defense - TDI 837,719 783,704 1,001,906 1,206,844 A4 Technologies - RCA 872,790 132,946 1,262,698 644,419 A4 Technologies - Elecjet (222,275) (272,099) (467,696) (576,445) A4 Aerospace - Vayu (1,414,806) (819,431) (2,241,731) (1,626,328) All Other (4,191,979) (3,167,735) (7,666,677) (5,508,728) $ (4,551,866) $ 1,539,806 $ (10,321,009) $ (2,459,754) The Company’s reportable segments as of June 30, 2023, and December 31, 2022, were as follows: As of June 30, 2023 As of December 31, 2022 Total assets A4 Construction Services - MSM $ 10,675,363 $ 11,309,049 A4 Construction Services - Excel 3,334,543 3,359,818 A4 Manufacturing - QCA 20,550,261 20,988,492 A4 Manufacturing - Alt Labs 28,335,277 26,636,905 A4 Defense - TDI 13,663,378 13,497,381 A4 Technologies - RCA 24,753,925 27,191,977 A4 Technologies - Elecjet 12,787,943 12,897,440 A4 Aerospace - Vayu 12,890,586 14,632,530 All Other 15,619,649 15,118,622 $ 142,610,925 $ 145,632,214 Goodwill A4 Construction Services - MSM $ 113,592 $ 113,592 A4 Construction Services - Excel — — A4 Manufacturing - QCA 1,963,761 1,963,761 A4 Manufacturing - Alt Labs 4,410,564 4,410,564 A4 Defense - TDI 6,426,786 6,426,786 A4 Technologies - RCA 1,355,728 1,355,728 A4 Technologies - Elecjet 6,496,343 6,496,343 A4 Aerospace - Vayu — — All Other 1,913,310 1,913,310 $ 22,680,084 $ 22,680,084 Accounts receivable, net A4 Construction Services - MSM $ 4,373,429 $ 5,188,521 A4 Construction Services - Excel 386,429 288,243 A4 Manufacturing - QCA 2,768,483 3,867,141 A4 Manufacturing - Alt Labs 2,458,636 1,833,502 A4 Defense - TDI 2,207,665 1,905,314 A4 Technologies - RCA 3,669,480 3,232,559 A4 Technologies - Elecjet 6,302 12,888 A4 Aerospace - Vayu — — All Other 758,324 811,776 $ 16,628,748 $ 17,139,944 |
Organization and Basis of Pre_2
Organization and Basis of Presentation (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||||||||
Jun. 30, 2023 | Mar. 31, 2023 | [1] | Jun. 30, 2022 | [1] | Mar. 31, 2022 | [1] | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | ||
Schedule of Investments [Line Items] | |||||||||||
Net loss | $ 4,551,866 | [1] | $ 5,769,143 | $ (1,539,806) | $ 3,999,560 | $ 10,321,009 | $ 2,459,754 | ||||
Net cash provided by (used) in operating activities | 2,477,701 | $ (7,237,442) | |||||||||
Working capital | 1,600,000 | 1,600,000 | |||||||||
Decrease in working capital | 14,000,000 | ||||||||||
Lines of credit | 13,700,000 | 13,700,000 | |||||||||
Lines of credit | 8,699,609 | 8,699,609 | $ 7,426,814 | ||||||||
Revolving Credit Facility | Line of Credit | |||||||||||
Schedule of Investments [Line Items] | |||||||||||
Maximum borrowing capacity | 35,000,000 | 35,000,000 | |||||||||
Remaining borrowing capacity | 4,400,000 | 4,400,000 | |||||||||
Revolving Credit Facility | Four Revolving Lines of Credit | Line of Credit | |||||||||||
Schedule of Investments [Line Items] | |||||||||||
Maximum borrowing capacity | 35,000,000 | 35,000,000 | |||||||||
Revolving Credit Facility | Capital Expenditure Line of Credit | Line of Credit | |||||||||||
Schedule of Investments [Line Items] | |||||||||||
Maximum borrowing capacity | $ 500,000 | $ 500,000 | |||||||||
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Cash (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Cash equivalents | $ 0 | $ 0 |
Bank balances | 3,900,000 | 3,200,000 |
Uninsured cash | $ 2,500,000 | $ 2,000,000 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Major Customers & Vendors (Details) | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue | Customer Concentration Risk | Customer One | ||
Product Information [Line Items] | ||
Concentration risk, percentage | 12% | |
Revenue | Customer Concentration Risk | Prime Contractors | ||
Product Information [Line Items] | ||
Concentration risk, percentage | 10% | 10% |
Cost of Goods and Service | Vendor Concentration Risk | A4 Technologies - RCA Segment | ||
Product Information [Line Items] | ||
Concentration risk, percentage | 17% |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Schedule of Inventory (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Raw materials | $ 9,726,538 | $ 9,116,824 |
Work in process | 3,528,187 | 3,165,876 |
Finished goods | 10,764,288 | 12,975,669 |
Inventory | $ 24,019,013 | $ 25,258,369 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Equity Method Investments (Details) - Battery Materials Company - USD ($) $ in Millions | Jun. 30, 2023 | Feb. 28, 2023 |
Schedule of Equity Method Investments [Line Items] | ||
Equity method investment | $ 0.3 | |
Equity method investment, ownership percentage | 8% | 10% |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Research and Development (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Accounting Policies [Abstract] | ||||
Research and development | $ 1,612,530 | $ 394,835 | $ 1,726,436 | $ 586,765 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Accounting Policies [Abstract] | |||||
Antidilutive securities (in shares) | 2,894,897 | 1,098,050 | |||
Basic EPS | |||||
Net loss | $ (4,551,866) | $ 1,539,806 | $ (10,321,009) | $ (2,459,754) | |
Net income (loss) (in shares) | [1] | 25,103,271 | 22,899,822 | 25,076,452 | 22,890,560 |
Net income (loss) (in dollars per share) | $ (0.18) | $ 0.07 | $ (0.41) | $ (0.11) | |
Effect of Dilutive Securities | |||||
Effect of Dilutive Securities Stock options and warrants | $ 0 | $ 0 | $ 0 | $ 0 | |
Effect of Dilutive Securities Stock options and warrants (in shares) | 0 | 0 | 0 | 0 | |
Dilute EPS | |||||
Net income (loss) | $ (4,551,866) | $ 1,539,806 | $ (10,321,009) | $ (2,459,754) | |
Net income (loss) (in shares) | [1] | 25,103,271 | 22,899,822 | 25,076,452 | 22,890,560 |
Net income (loss) (in dollars per share) | $ (0.18) | $ 0.07 | $ (0.41) | $ (0.11) | |
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
Summary of Significant Accou_10
Summary of Significant Accounting Policies - Schedule of Disaggregation of Revenue (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Total revenues | $ 28,022,026 | $ 25,271,126 | $ 52,383,739 | $ 50,863,280 |
Construction Services | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 3,660,886 | 5,669,259 | 7,806,890 | 9,725,463 |
Manufacturing | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 12,886,116 | 7,530,475 | 22,206,937 | 16,178,570 |
Defense | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 2,413,363 | 2,472,207 | 5,383,450 | 5,160,188 |
Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 8,660,465 | 9,255,658 | 16,216,383 | 19,049,646 |
Aerospace | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 401,196 | 343,527 | 770,079 | 749,413 |
Sale of goods | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 21,546,581 | 16,786,133 | 38,423,320 | 35,228,216 |
Sale of goods | Construction Services | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 0 | 0 | 0 | 0 |
Sale of goods | Manufacturing | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 12,886,116 | 7,530,475 | 22,206,937 | 16,178,570 |
Sale of goods | Defense | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 0 | 0 | 0 | 0 |
Sale of goods | Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 8,660,465 | 9,255,658 | 16,216,383 | 19,049,646 |
Sale of goods | Aerospace | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 0 | 0 | 0 | 0 |
Sale of services | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 6,475,445 | 8,484,993 | 13,960,419 | 15,635,064 |
Sale of services | Construction Services | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 3,660,886 | 5,669,259 | 7,806,890 | 9,725,463 |
Sale of services | Manufacturing | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 0 | 0 | 0 | 0 |
Sale of services | Defense | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 2,413,363 | 2,472,207 | 5,383,450 | 5,160,188 |
Sale of services | Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | 0 | 0 | 0 | 0 |
Sale of services | Aerospace | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenues | $ 401,196 | $ 343,527 | $ 770,079 | $ 749,413 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Finance Leases | ||
2024 | $ 1,938,360 | |
2025 | 1,944,246 | |
2026 | 1,848,756 | |
2027 | 1,890,900 | |
2028 | 1,932,830 | |
Thereafter | 13,879,717 | |
Total payments | 23,434,809 | |
Less: imputed interest | (8,474,940) | |
Total obligation | 14,959,869 | |
Less: current portion | (764,267) | $ (725,302) |
Non-current financing leases obligations | 14,195,602 | 14,592,813 |
Operating Leases | ||
2024 | 2,412,039 | |
2025 | 2,304,494 | |
2026 | 1,784,228 | |
2027 | 1,823,449 | |
2028 | 1,646,961 | |
Thereafter | 12,457,744 | |
Total payments | 22,428,915 | |
Less: imputed interest | (6,462,880) | |
Total obligation | 15,966,035 | 16,581,379 |
Less: current portion | (1,518,842) | (1,318,885) |
Non-current financing leases obligations | $ 14,447,193 | $ 15,262,494 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Finance Leases | ||
Finance lease, right-of-use asset, amortization | $ 625,908 | $ 625,908 |
Finance lease, interest expense | $ 607,895 | 633,610 |
Finance lease, weighted average remaining lease term | 11 years 6 months | |
Finance lease, weighted average discount rate (as a percent) | 8.01% | |
Operating Leases | ||
Operating lease, cost | $ 1,292,535 | 253,121 |
Operating lease, payments | $ 789,282 | 251,398 |
Operating lease, weighted average remaining lease term | 11 years 6 months | |
Operating lease, weighted average discount rate (as a percent) | 6.01% | |
Cost of Sales | ||
Finance Leases | ||
Finance lease, right-of-use asset, amortization | $ 89,006 | 0 |
Operating Leases | ||
Operating lease, cost | $ 372,352 | $ 0 |
Leases - Schedule of Right of U
Leases - Schedule of Right of Use Assets and Lease Liabilities (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Assets | ||
Operating lease assets | $ 15,704,511 | $ 16,407,566 |
Liabilities | ||
Current Operating lease liability | 1,518,842 | 1,318,885 |
Non-current Operating lease liability | 14,447,193 | 15,262,494 |
Total obligation | $ 15,966,035 | $ 16,581,379 |
Debt - Schedule of Notes Payabl
Debt - Schedule of Notes Payable (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Total current | $ 15,425,081 | $ 10,627,950 |
Total | 21,627,540 | 22,109,820 |
Line of Credit | Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Total current | 8,699,609 | 7,426,814 |
Long-term debt | 4,058,411 | 7,215,520 |
Secured Debt and Notes Payable | ||
Debt Instrument [Line Items] | ||
Long-term debt | 2,144,048 | 4,266,350 |
Secured Debt | ||
Debt Instrument [Line Items] | ||
Total current | 76,072 | 68,410 |
Related party term notes, current portion | ||
Debt Instrument [Line Items] | ||
Total current | 555,000 | 0 |
Notes Payable | ||
Debt Instrument [Line Items] | ||
Total current | $ 6,094,400 | $ 3,132,726 |
Debt - Future Scheduled Maturit
Debt - Future Scheduled Maturities of Outstanding Notes Payable (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Debt Disclosure [Abstract] | ||
2024 | $ 15,425,081 | |
2025 | 1,743,815 | |
2026 | 669,034 | |
2027 | 123,428 | |
2028 | 3,594,396 | |
Thereafter | 71,786 | |
Total | $ 21,627,540 | $ 22,109,820 |
Debt - Narrative (Details)
Debt - Narrative (Details) | 1 Months Ended | 6 Months Ended | |||
May 31, 2023 USD ($) | Jun. 30, 2023 USD ($) lineOfCredit | Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | |
Debt Instrument [Line Items] | |||||
Note balance | $ 21,627,540 | $ 22,109,820 | |||
A4 Manufacturing - QCA Segment | Operating Segments | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, face amount | 5,000,000 | $ 7,000,000 | |||
Notes Payable to Banks | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, face amount | $ 200,000 | ||||
Debt instrument term | 9 months | ||||
Interest rate (as a percent) | 15% | ||||
Notes Payable | |||||
Debt Instrument [Line Items] | |||||
Daily late fee | $ 575 | ||||
Line of Credit | Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Number of lines of credit | lineOfCredit | 4 | ||||
Maximum borrowing capacity | $ 35,000,000 | ||||
Net proceeds/(repayments) from lines of credit | 12,800,000 | ||||
Remaining borrowing capacity | $ 4,400,000 | ||||
Line of Credit | Revolving Credit Facility | Capital Expenditure Line of Credit | |||||
Debt Instrument [Line Items] | |||||
Number of lines of credit | lineOfCredit | 1 | ||||
Maximum borrowing capacity | $ 500,000 | ||||
Line of Credit | Minimum | Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Debt instrument term | 1 year | ||||
Line of Credit | Minimum | Revolving Credit Facility | Prime Rate | |||||
Debt Instrument [Line Items] | |||||
Basis spread on variable rate (as a percent) | 2.50% | ||||
Line of Credit | Maximum | Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Debt instrument term | 5 years | ||||
Line of Credit | Maximum | Revolving Credit Facility | Prime Rate | |||||
Debt Instrument [Line Items] | |||||
Basis spread on variable rate (as a percent) | 4.25% | ||||
Alan Martin | Notes Payable | |||||
Debt Instrument [Line Items] | |||||
Note balance | $ 2,900,000 | $ 2,900,000 | |||
Interest Payable, Current | $ 2,000,000 | ||||
Default rate (as a percent) | 10% |
Convertible Debt (Details)
Convertible Debt (Details) - USD ($) | 1 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | May 31, 2023 | Jun. 30, 2023 | Jun. 30, 2022 | |
Debt Instrument [Line Items] | ||||
Proceeds from issuance of convertible notes, non-related party | $ 243,529 | $ 2,090,000 | $ 0 | |
Convertible Note Payable 1 | ||||
Debt Instrument [Line Items] | ||||
Convertible Debt | $ 185,476 | 185,476 | ||
Convertible Note Payable 2 | ||||
Debt Instrument [Line Items] | ||||
Convertible Debt | $ 285,836 | 285,836 | ||
Restricted Stock | ||||
Debt Instrument [Line Items] | ||||
Shares granted (in shares) | 67,400 | 13,750 | ||
Convertible Notes Payable | ||||
Debt Instrument [Line Items] | ||||
Debt instrument term | 1 year | 1 year | ||
Debt instrument, face amount | $ 1,700,000 | $ 400,000 | $ 1,700,000 | |
Interest rate (as a percent) | 12% | 12% | 12% | |
Original issue discount | $ 242,120 | $ 24,500 | $ 242,120 | |
Proceeds from issuance of convertible notes, non-related party | $ 757,280 | |||
Convertible Notes Payable | Warrants 2 | ||||
Debt Instrument [Line Items] | ||||
Warrants outstanding | 3,579 | 3,579 | ||
Fair value of warrants issued | $ 6,764 | $ 6,764 | ||
Convertible Notes Payable | Warrants 1 | ||||
Debt Instrument [Line Items] | ||||
Warrants outstanding | 200,000 | 200,000 | ||
Fair value of warrants issued | $ 378,000 | $ 378,000 | ||
Convertible Notes Payable | Restricted Stock | ||||
Debt Instrument [Line Items] | ||||
Shares granted (in shares) | 1,200,000 | 196,250 |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | |||||
Jun. 30, 2023 | May 31, 2023 | Apr. 30, 2023 | May 12, 2023 | May 11, 2023 | Dec. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based compensation expense not yet recognized, options | $ 0.8 | |||||
Restricted Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Shares granted (in shares) | 67,400 | 13,750 | ||||
Restricted Stock | Convertible Notes Payable | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Shares granted (in shares) | 1,200,000 | 196,250 | ||||
Class A Common Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Common stock, shares authorized (in shares) | 200,000,000 | 200,000,000 | 295,000,000 | 200,000,000 | ||
Common stock, shares outstanding (in shares) | 23,974,657 | 22,504,669 | 180,037,350 | 22,303,333 | ||
Common stock, shares issued (in shares) | 23,974,657 | 22,504,669 | 180,037,350 | 22,303,333 | ||
Conversion of stock, shares issued (in shares) | 162,500 | |||||
Class B Common Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Common stock, shares authorized (in shares) | 10,000,000 | 10,000,000 | ||||
Common stock, shares outstanding (in shares) | 906,012 | 1,068,512 | ||||
Common stock, shares issued (in shares) | 906,012 | 1,068,512 | ||||
Stock converted (in shares) | 162,500 | |||||
Preferred Class B | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Stock converted (in shares) | 1 | |||||
Conversion of stock, shares issued (in shares) | 1 |
Stockholders' Equity - Stock Op
Stockholders' Equity - Stock Option Activity (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Options | ||
Outstanding, beginning balance (in shares) | 386,751 | |
Granted (in shares) | 0 | |
Forfeited (in shares) | (16,844) | |
Exercised (in shares) | 0 | |
Outstanding, ending balance (in shares) | 369,907 | 386,751 |
Exercisable (in shares) | 159,001 | |
Weighted Average Exercise Price | ||
Outstanding, beginning balance (in dollars per share) | $ 4.39 | |
Granted (in dollars per share) | 0 | |
Forfeited (in dollars per share) | 6.16 | |
Exercised (in dollars per share) | 0 | |
Outstanding, ending balance (in dollars per share) | 4.31 | $ 4.39 |
Exercisable (in dollars per share) | $ 1.85 | |
Weighted Average Remaining Contractual Life (Years) | ||
Outstanding | 7 years 4 months 17 days | 7 years 11 months 8 days |
Exercisable | 5 years 5 months 15 days | |
Aggregate Intrinsic Value | ||
Outstanding | $ 193,492 | $ 463,495 |
Exercisable | $ 193,492 |
Stockholders' Equity - Options
Stockholders' Equity - Options Outstanding and Exercisable (Details) | 6 Months Ended |
Jun. 30, 2023 $ / shares shares | |
Options Outstanding | |
Number of Shares (in shares) | shares | 369,907 |
Options Exercisable | |
Number of Shares (in shares) | shares | 159,001 |
Exercise Price $0.40 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Exercise price (in dollars per share) | $ 0.40 |
Exercise price (in dollars per share) | $ 0.40 |
Options Outstanding | |
Number of Shares (in shares) | shares | 111,438 |
Weighted Average Remaining Life (Years) | 5 years 3 days |
Weighted Average Exercise Price (in dollars per share) | $ 0.40 |
Options Exercisable | |
Number of Shares (in shares) | shares | 111,438 |
Weighted Average Exercise Price (in dollars per share) | $ 0.40 |
Exercise Price $0.80 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Exercise price (in dollars per share) | 0.80 |
Exercise price (in dollars per share) | $ 0.80 |
Options Outstanding | |
Number of Shares (in shares) | shares | 10,625 |
Weighted Average Remaining Life (Years) | 4 years 9 months 10 days |
Weighted Average Exercise Price (in dollars per share) | $ 0.80 |
Options Exercisable | |
Number of Shares (in shares) | shares | 10,625 |
Weighted Average Exercise Price (in dollars per share) | $ 0.80 |
Exercise Price $6.16 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Exercise price (in dollars per share) | 6.16 |
Exercise price (in dollars per share) | $ 6.16 |
Options Outstanding | |
Number of Shares (in shares) | shares | 234,340 |
Weighted Average Remaining Life (Years) | 8 years 10 months 2 days |
Weighted Average Exercise Price (in dollars per share) | $ 6.16 |
Options Exercisable | |
Number of Shares (in shares) | shares | 23,434 |
Weighted Average Exercise Price (in dollars per share) | $ 6.16 |
Exercise Price $7.20 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Exercise price (in dollars per share) | 7.20 |
Exercise price (in dollars per share) | $ 7.20 |
Options Outstanding | |
Number of Shares (in shares) | shares | 13,504 |
Weighted Average Remaining Life (Years) | 3 years 9 months 7 days |
Weighted Average Exercise Price (in dollars per share) | $ 7.20 |
Options Exercisable | |
Number of Shares (in shares) | shares | 13,504 |
Weighted Average Exercise Price (in dollars per share) | $ 7.20 |
Stockholders' Equity - Warrants
Stockholders' Equity - Warrants Activity (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Warrants | ||
Outstanding, beginning balance (in shares) | 386,751 | |
Granted (in shares) | 0 | |
Forfeited (in shares) | (16,844) | |
Exercised (in shares) | 0 | |
Outstanding, ending balance (in shares) | 369,907 | 386,751 |
Exercisable (in shares) | 159,001 | |
Weighted Average Exercise Price | ||
Outstanding, beginning balance (in dollars per share) | $ 4.39 | |
Granted (in dollars per share) | 0 | |
Forfeited (in dollars per share) | 6.16 | |
Exercised (in dollars per share) | 0 | |
Outstanding, ending balance (in dollars per share) | 4.31 | $ 4.39 |
Exercisable (in dollars per share) | $ 1.85 | |
Weighted Average Remaining Contractual Life (Years) | ||
Outstanding | 7 years 4 months 17 days | 7 years 11 months 8 days |
Exercisable | 5 years 5 months 15 days | |
Aggregate Intrinsic Value | ||
Outstanding | $ 193,492 | $ 463,495 |
Exercisable | $ 193,492 | |
Warrant | ||
Warrants | ||
Outstanding, beginning balance (in shares) | 2,321,411 | |
Granted (in shares) | 203,579 | |
Forfeited (in shares) | 0 | |
Exercised (in shares) | 0 | |
Outstanding, ending balance (in shares) | 2,524,990 | 2,321,411 |
Exercisable (in shares) | 2,524,990 | |
Weighted Average Exercise Price | ||
Outstanding, beginning balance (in dollars per share) | $ 11.78 | |
Granted (in dollars per share) | 3.51 | |
Forfeited (in dollars per share) | 0 | |
Exercised (in dollars per share) | 0 | |
Outstanding, ending balance (in dollars per share) | 11.12 | $ 11.78 |
Exercisable (in dollars per share) | $ 11.12 | |
Weighted Average Remaining Contractual Life (Years) | ||
Outstanding | 3 years 10 months 13 days | 4 years 3 months 21 days |
Granted | 5 years | |
Exercisable | 3 years 10 months 13 days | |
Aggregate Intrinsic Value | ||
Outstanding | $ 0 | $ 0 |
Exercisable | $ 0 |
Stockholders' Equity - Warran_2
Stockholders' Equity - Warrants Outstanding and Exercisable (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Number of Shares outstanding (in shares) | 369,907 | 386,751 |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 7 years 4 months 17 days | 7 years 11 months 8 days |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 4.31 | $ 4.39 |
Warrants Exercisable, Number of Shares (in shares) | 159,001 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 1.85 | |
Warrants 1 | Convertible Notes Payable | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants outstanding | 200,000 | |
Warrant exercise price (in dollar per share) | $ 3.50 | |
Fair value of warrants issued | $ 378,000 | |
Warrants 2 | Convertible Notes Payable | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants outstanding | 3,579 | |
Warrant exercise price (in dollar per share) | $ 4.20 | |
Fair value of warrants issued | $ 6,764 | |
Warrant | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Number of Shares outstanding (in shares) | 2,524,990 | 2,321,411 |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 3 years 10 months 13 days | 4 years 3 months 21 days |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 11.12 | $ 11.78 |
Warrants Exercisable, Number of Shares (in shares) | 2,524,990 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 11.12 | |
Warrant | Exercise price $52.80 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 52.80 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 52,084 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 1 year 7 months 20 days | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 52.80 | |
Warrants Exercisable, Number of Shares (in shares) | 52,084 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 52.80 | |
Warrant | Exercise price $20.16 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 20.16 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 49,604 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 1 year 5 months 12 days | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 20.16 | |
Warrants Exercisable, Number of Shares (in shares) | 49,604 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 20.16 | |
Warrant | Exercise price $24.80 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 24.80 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 535,716 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 3 years 4 months 28 days | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 24.80 | |
Warrants Exercisable, Number of Shares (in shares) | 535,716 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 24.80 | |
Warrant | Exercise price $24.64 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 24.64 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 53,572 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 3 years 4 months 24 days | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 24.64 | |
Warrants Exercisable, Number of Shares (in shares) | 53,572 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 24.64 | |
Warrant | Exercise price $5.52 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 5.52 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 1,630,435 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 4 years 14 days | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 5.52 | |
Warrants Exercisable, Number of Shares (in shares) | 1,630,435 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 5.52 | |
Warrant | Exercise price $3.50 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 3.50 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 200,000 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 5 years | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 3.50 | |
Warrants Exercisable, Number of Shares (in shares) | 200,000 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 3.50 | |
Warrant | Exercise price $4.20 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Warrants Outstanding, Exercise Price (in dollars per share) | $ 4.20 | |
Warrants Outstanding, Number of Shares outstanding (in shares) | 3,579 | |
Warrants Outstanding, Weighted Average Remaining Life (Years) | 5 years | |
Warrants Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 4.20 | |
Warrants Exercisable, Number of Shares (in shares) | 3,579 | |
Warrants Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 4.20 |
Stockholders' Equity - Valuatio
Stockholders' Equity - Valuation Assumptions (Details) | Jun. 30, 2023 |
Stock price | |
Class of Warrant or Right [Line Items] | |
Warrants outstanding, measurement input | 1.89 |
Risk-free interest rate | |
Class of Warrant or Right [Line Items] | |
Warrants outstanding, measurement input | 4.5 |
Expected life of the warrants | |
Class of Warrant or Right [Line Items] | |
Warrants outstanding, measurement input | 2.5 |
Expected volatility | |
Class of Warrant or Right [Line Items] | |
Warrants outstanding, measurement input | 1,242 |
Expected dividend yield | |
Class of Warrant or Right [Line Items] | |
Warrants outstanding, measurement input | 0 |
Segment Reporting (Details)
Segment Reporting (Details) | 3 Months Ended | 6 Months Ended | |||||||||
Jun. 30, 2023 USD ($) | Mar. 31, 2023 USD ($) | [1] | Jun. 30, 2022 USD ($) | Mar. 31, 2022 USD ($) | [1] | Jun. 30, 2023 USD ($) segment | Jun. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | |||
Segment Reporting [Abstract] | |||||||||||
Number of operating segments | segment | 8 | ||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | $ 28,022,026 | $ 25,271,126 | $ 52,383,739 | $ 50,863,280 | |||||||
Gross profit (loss) | 7,787,090 | 6,160,543 | 13,003,546 | 11,798,000 | |||||||
Income (loss) from operations | (3,718,894) | 2,371,760 | (8,859,367) | (1,384,395) | |||||||
Depreciation and amortization | 1,585,356 | 1,548,792 | 3,113,139 | 3,018,456 | |||||||
Interest expense | 1,108,745 | 962,474 | 2,107,615 | 1,571,435 | |||||||
Net income (loss) | (4,551,866) | [1] | $ (5,769,143) | 1,539,806 | [1] | $ (3,999,560) | (10,321,009) | (2,459,754) | |||
Total assets | 142,610,925 | 142,610,925 | $ 145,632,214 | ||||||||
Goodwill | 22,680,084 | 22,680,084 | 22,680,084 | ||||||||
Accounts receivable, net | 16,628,748 | 16,628,748 | 17,139,944 | ||||||||
All Other | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 1,176,325 | 673,735 | 2,447,472 | 1,559,718 | |||||||
Gross profit (loss) | 398,676 | 293,225 | 772,244 | 646,699 | |||||||
Income (loss) from operations | (3,788,794) | (2,587,090) | (7,143,755) | (5,012,709) | |||||||
Depreciation and amortization | 317,255 | 277,280 | 595,968 | 554,721 | |||||||
Interest expense | 600,494 | 534,018 | 1,087,498 | 829,747 | |||||||
Net income (loss) | (4,191,979) | (3,167,735) | (7,666,677) | (5,508,728) | |||||||
Total assets | 15,619,649 | 15,619,649 | 15,118,622 | ||||||||
Goodwill | 1,913,310 | 1,913,310 | 1,913,310 | ||||||||
Accounts receivable, net | 758,324 | 758,324 | 811,776 | ||||||||
A4 Construction Services - MSM Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 3,550,392 | 5,326,296 | 7,363,532 | 9,093,686 | |||||||
Gross profit (loss) | 549,807 | 191,788 | 781,695 | 655,594 | |||||||
Income (loss) from operations | (150,608) | (152,882) | (555,021) | (468,580) | |||||||
Depreciation and amortization | 178,665 | 171,342 | 352,963 | 337,746 | |||||||
Interest expense | 98,163 | 124,220 | 211,873 | 227,245 | |||||||
Net income (loss) | (248,771) | (276,934) | (729,371) | (639,301) | |||||||
Total assets | 10,675,363 | 10,675,363 | 11,309,049 | ||||||||
Goodwill | 113,592 | 113,592 | 113,592 | ||||||||
Accounts receivable, net | 4,373,429 | 4,373,429 | 5,188,521 | ||||||||
A4 Construction Services - Excel Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 110,494 | 342,963 | 443,358 | 631,777 | |||||||
Gross profit (loss) | (373,950) | (26,468) | (523,958) | (125,442) | |||||||
Income (loss) from operations | (578,989) | (238,956) | (1,011,070) | (558,946) | |||||||
Depreciation and amortization | 67,524 | 132,917 | 135,049 | 132,917 | |||||||
Interest expense | 60,196 | 61,643 | 120,766 | 123,628 | |||||||
Net income (loss) | (639,185) | (300,599) | (1,131,836) | (682,574) | |||||||
Total assets | 3,334,543 | 3,334,543 | 3,359,818 | ||||||||
Goodwill | 0 | 0 | 0 | ||||||||
Accounts receivable, net | 386,429 | 386,429 | 288,243 | ||||||||
A4 Manufacturing - QCA Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 5,319,687 | 4,241,382 | 9,511,330 | 8,560,242 | |||||||
Gross profit (loss) | 1,786,189 | 1,149,049 | 2,683,904 | 2,176,233 | |||||||
Income (loss) from operations | 446,516 | 270,804 | 465,613 | 685,252 | |||||||
Depreciation and amortization | 113,673 | 108,304 | 230,552 | 208,783 | |||||||
Interest expense | 171,005 | 87,601 | 334,650 | 123,890 | |||||||
Net income (loss) | 275,944 | 161,763 | 131,757 | 535,630 | |||||||
Total assets | 20,550,261 | 20,550,261 | 20,988,492 | ||||||||
Goodwill | 1,963,761 | 1,963,761 | 1,963,761 | ||||||||
Accounts receivable, net | 2,768,483 | 2,768,483 | 3,867,141 | ||||||||
A4 Manufacturing - Alt Labs Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 6,787,129 | 2,958,885 | 11,014,043 | 6,783,023 | |||||||
Gross profit (loss) | 1,778,676 | 857,997 | 2,727,428 | 1,759,476 | |||||||
Income (loss) from operations | 181,351 | 5,190,788 | (377,774) | 4,203,305 | |||||||
Depreciation and amortization | 225,654 | 253,948 | 434,208 | 560,983 | |||||||
Interest expense | 84,979 | 94,561 | 149,659 | 151,677 | |||||||
Net income (loss) | 178,697 | 5,298,191 | (480,059) | 4,186,729 | |||||||
Total assets | 28,335,277 | 28,335,277 | 26,636,905 | ||||||||
Goodwill | 4,410,564 | 4,410,564 | 4,410,564 | ||||||||
Accounts receivable, net | 2,458,636 | 2,458,636 | 1,833,502 | ||||||||
A4 Defense - TDI Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 2,413,363 | 2,472,207 | 5,383,450 | 5,160,188 | |||||||
Gross profit (loss) | 944,550 | 1,285,732 | 1,561,132 | 2,128,921 | |||||||
Income (loss) from operations | 829,235 | 783,704 | 1,010,769 | 1,206,844 | |||||||
Depreciation and amortization | 72,433 | 72,090 | 144,866 | 144,180 | |||||||
Interest expense | 16,598 | 0 | 33,945 | 0 | |||||||
Net income (loss) | 837,719 | 783,704 | 1,001,906 | 1,206,844 | |||||||
Total assets | 13,663,378 | 13,663,378 | 13,497,381 | ||||||||
Goodwill | 6,426,786 | 6,426,786 | 6,426,786 | ||||||||
Accounts receivable, net | 2,207,665 | 2,207,665 | 1,905,314 | ||||||||
A4 Technologies - RCA Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 8,538,620 | 8,910,276 | 15,992,043 | 18,147,535 | |||||||
Gross profit (loss) | 2,752,026 | 2,159,923 | 5,126,204 | 4,344,251 | |||||||
Income (loss) from operations | 944,686 | 193,377 | 1,420,550 | 759,667 | |||||||
Depreciation and amortization | 244,805 | 170,053 | 489,609 | 340,099 | |||||||
Interest expense | 71,896 | 60,431 | 157,852 | 115,248 | |||||||
Net income (loss) | 872,790 | 132,946 | 1,262,698 | 644,419 | |||||||
Total assets | 24,753,925 | 24,753,925 | 27,191,977 | ||||||||
Goodwill | 1,355,728 | 1,355,728 | 1,355,728 | ||||||||
Accounts receivable, net | 3,669,480 | 3,669,480 | 3,232,559 | ||||||||
A4 Technologies - Elecjet Sgement | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 121,845 | 345,382 | 224,340 | 902,111 | |||||||
Gross profit (loss) | (53,000) | 249,297 | (126,809) | 187,268 | |||||||
Income (loss) from operations | (222,275) | (268,554) | (467,696) | (572,900) | |||||||
Depreciation and amortization | 105,668 | 103,633 | 211,334 | 205,133 | |||||||
Interest expense | 0 | 0 | 0 | 0 | |||||||
Net income (loss) | (222,275) | (272,099) | (467,696) | (576,445) | |||||||
Total assets | 12,787,943 | 12,787,943 | 12,897,440 | ||||||||
Goodwill | 6,496,343 | 6,496,343 | 6,496,343 | ||||||||
Accounts receivable, net | 6,302 | 6,302 | 12,888 | ||||||||
A4 Aerospace - Vayu Segment | Operating Segments | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues, net | 4,171 | 0 | 4,171 | 25,000 | |||||||
Gross profit (loss) | 4,116 | 0 | 1,706 | 25,000 | |||||||
Income (loss) from operations | (1,380,016) | (819,431) | (2,200,983) | (1,626,328) | |||||||
Depreciation and amortization | 259,679 | 259,225 | 518,590 | 533,894 | |||||||
Interest expense | 5,414 | 0 | 11,372 | 0 | |||||||
Net income (loss) | (1,414,806) | $ (819,431) | (2,241,731) | $ (1,626,328) | |||||||
Total assets | 12,890,586 | 12,890,586 | 14,632,530 | ||||||||
Goodwill | 0 | 0 | 0 | ||||||||
Accounts receivable, net | $ 0 | $ 0 | $ 0 | ||||||||
[1]Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 6, Stockholders' Equity for details. |
Commitment and Contingencies (D
Commitment and Contingencies (Details) | 1 Months Ended | ||||||||||||||||
Dec. 01, 2024 USD ($) | Dec. 01, 2023 USD ($) | Oct. 31, 2023 USD ($) | Aug. 11, 2023 shares | Aug. 03, 2023 USD ($) | Nov. 28, 2021 USD ($) | May 31, 2023 USD ($) | Feb. 28, 2023 USD ($) | Dec. 31, 2022 USD ($) | Nov. 30, 2022 USD ($) | Jun. 30, 2022 USD ($) | Oct. 31, 2021 USD ($) | Oct. 31, 2021 complaint | Oct. 31, 2021 lawsuit | Oct. 31, 2021 shares | Aug. 31, 2020 USD ($) | Jun. 30, 2023 USD ($) | |
Other Commitments [Line Items] | |||||||||||||||||
2023 Warrant service agreement | $ 66,626 | ||||||||||||||||
2024 Warrant service agreement | 59,964 | ||||||||||||||||
Loss contingency, damages sought, value | $ 610,000 | $ 100,000 | $ 500,000 | $ 2,300,000 | $ 213,000 | ||||||||||||
Horizon Well Testing Case | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Damages paid value | $ 3,300,000 | ||||||||||||||||
Loss contingency interest rate (as a percent) | 8% | ||||||||||||||||
Daily late fee | 575 | ||||||||||||||||
Horizon Well Testing Case | Forecast | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Damages paid value | $ 900,000 | $ 2,000,000 | |||||||||||||||
Note payable | $ 1,800,000 | ||||||||||||||||
Monthly note payable payment | $ 75,000 | ||||||||||||||||
Horizon Well Testing Case | Subsequent Event | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Damages paid value | $ 100,000 | ||||||||||||||||
Number of shares settled | shares | 250,000 | ||||||||||||||||
Complaints In Discount Court of Oklahoma Country State of Oklahoma | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Loss contingency, number of claims | 3 | 3 | |||||||||||||||
Complaints In Discount Court of Oklahoma Country State of Oklahoma | Settled Litigation | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Number of shares settled | shares | 4,688 | ||||||||||||||||
Litigation settlement amount | $ 24,375 | ||||||||||||||||
Licensing Agreement | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Minimum annual payment, reminder of fiscal year | 550,000 | ||||||||||||||||
Minimum annual payment, year one | 600,000 | ||||||||||||||||
Minimum annual payment, year two | 620,000 | ||||||||||||||||
Minimum annual payment, year three | 660,000 | ||||||||||||||||
Minimum annual payment, year four | $ 700,000 | ||||||||||||||||
Licensing Agreement | Minimum | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Royalty fee | 2.50% | ||||||||||||||||
Licensing Agreement | Maximum | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Royalty fee | 3.50% | ||||||||||||||||
Royalty Agreements | |||||||||||||||||
Other Commitments [Line Items] | |||||||||||||||||
Payment as a percentage of net sales | 1.50% | ||||||||||||||||
Royalty agreement, term | 10 years | ||||||||||||||||
Other commitment | $ 50,000,000 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Thousands | 1 Months Ended | ||||||
Dec. 01, 2024 | Dec. 01, 2023 | Oct. 31, 2023 | Aug. 11, 2023 | Aug. 03, 2023 | Aug. 31, 2020 | Jul. 31, 2023 | |
Subsequent Event | Purchase Order, G1 MKIII Fixed Wing UAV | |||||||
Subsequent Event [Line Items] | |||||||
Other commitment | $ 5,250 | ||||||
Down payment percentage | 10% | ||||||
Horizon Well Testing Case | |||||||
Subsequent Event [Line Items] | |||||||
Damages paid value | $ 3,300 | ||||||
Horizon Well Testing Case | Forecast | |||||||
Subsequent Event [Line Items] | |||||||
Damages paid value | $ 900 | $ 2,000 | |||||
Note payable | $ 1,800 | ||||||
Monthly note payable payment | $ 75 | ||||||
Horizon Well Testing Case | Subsequent Event | |||||||
Subsequent Event [Line Items] | |||||||
Damages paid value | $ 100 | ||||||
Number of shares settled | 250,000 |